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Bezchybná a včasná replikace molekul DNA je jedním z rozhodujících momentů životního 
cyklu každého organismu. Jakýkoliv defekt, ať už v časování či lokalizaci, může tento delikátní, 
na přesnosti závislý mechanismus uvrhnout do stavu takzvaného replikačního stresu. Některé 
z překážek blokujících postup replikační vidličky obsahují proteinovou složku. V průběhu evoluce 
se tak vyvinuly specializované proteasy, zodpovědné právě za uvolňování replikačního stresu. 
Kompletní paleta těchto proteolytických enzymů, stejně jako jejich substrátový repertoár a detailní 
molekulární mechanismus jejich zapojení v obraně proti DNA replikačnímu stresu však dosud 
nebyly objasněny. Tato disertační práce se zabývá rolí evolučně konzervovaných aspartátových 
proteas z rodiny proteinů podobných Ddi1 v proteolytické odpovědi na DNA replikační stres. 
V této práci byly strukturně a biofyzikálně charakterisováni členové rodiny Ddi1 podobných 
proteinů kvasinkového a lidského původu, byly prozkoumány jejich interakce s ubikvitinem, stejně 
jako s polyubikvitinovými řetězci. V neposlední řadě byla též mutantního kvasinkového kmene, 
který vedle genu pro DDI1 postrádá také gen pro DNA aktivovanou metalloproteasu WSS1, 
identifikována přecitlivělost na hydroxymočovinu, známý inhibitor replikace DNA. Detailní rozbor 
role kvasinkové DDI1 v zprostředkování tolerance vůči působení hydroxymočoviny odkryl zásadní 
roli proteolytické ativity domény podobné retrovirovým proteasám, stejně jako nepostradatelnost 
svazku alfa helixů v sekvenci bezprostředně předcházejících proteasovou doménu. Předkládané 
výsledky tak poskytují experimentální základ pro nový mechanismus odpovědi na DNA replikační 




Accurate, timely replication of a DNA molecule is a pivotal moment in the life cycle of every 
living organism. Any temporal or spatial defect putting the fine-tuned replication machinery off 
balance causes the so-called replication stress. As the replication machinery consists mainly of 
enzymes and other proteins, it is not surprising that many of the obstacles most severely blocking 
the replication machinery progress are of protein origin. Therefore, specialized proteases 
responsible for relieving replication stress matured during evolution. However, neither the full 
repertoire of proteolytic enzymes and their particular substrates taking place in countering the 
DNA replication stress nor detailed molecular mechanisms involved remain unknown. This thesis 
describes how conserved putative aspartic proteases of the Ddi1-like family engage in countering 
DNA replication stress via a proteolysis dependent mechanism. We structurally and biophysically 
characterized yeast and human members of the Ddi1-like family, explored their interactions with 
ubiquitin and polyubiquitin chains, and identified hypersensitivity to DNA replication inhibitor 
hydroxyurea in a yeast strain double deleted for DDI1 gene together with a DNA dependent 
metalloprotease WSS1. Detailed analysis of the DDI1 role in hydroxyurea tolerance showed a 
crucial role for the proteolytic activity of the aspartic retroviral protease-like domain and the 
essential role of the helical bundle directly preceding the protease domain. Our results provide an 
experimental foundation for a novel dual protease-based mechanism allowing yeast cells to 
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1. INTRODUCTION 
The primary objective of every living organism is to pass its genetic information, stored in 
the form of deoxyribonucleic acid (DNA), in the unchanged and intact form to the next generation. 
In every eukaryotic cell, from single-cell yeast and protozoa to cells constituting the human body, 
the process of passing genetic information revolves around a fundamental biological oscillator, the 
cell cycle. Here, in a repetitive series of events cell grows, accumulates necessary factors, building 
blocks, and nutrients, duplicates the complete genetic material, and then divides into two genetically 
identical daughter cells. The whole process, depicted in the figure 1, can be divided into four phases. 
In the first, G1 phase, a cell enhances protein synthesis, increases its pool of mitochondria, 
ribosomes, and other important components, and grows in size. The second phase, called S or 
synthetic, is marked by duplication of the cell's genetic material. Proteosynthesis is downregulated 
and energy resources of a cell are redirected toward DNA replication. The S phase is followed by 
another growth phase, G2, in which proteosynthesis is restarted, the cell grows rapidly and 
generates material for the division. The last phase of the cycle harbours the most dramatic changes 
in cellular architecture. In M, or mitotic, phase the previously doubled DNA condensates in tightly 
packed chromosomes, a microtubule-based spindle is then formed, and sister chromatids of 
chromosomes are separated and transported to the opposite ends of the cell. In an animal cell, 
mitosis is preceded by disassembly of the nuclear membrane, whereas in fungi such as S. cerevisiae 
mitosis occurs inside an intact nucleus. Separation of sister chromatids and eventual nuclear 
envelope reformation is followed by cytokinesis, where the cell divides its cytoplasmatic content 
roughly in halves, remodels the cytoplasmic membrane, and separates into two daughter cells. In a 
pathway alternative to committing to the cell cycle progression, a cell can exit the cycle in a G1 
phase and transfer to the G0 phase, a resting phase in which a cell can commit to full differentiation. 
Progression through the cell cycle and proper separation of its phases is directed by the activity of 
Cyclin-Dependent Kinases (CDK) and timely expression and degradation of their interaction 
partners, cyclins [Vermeulen et al., 2003].  
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Figure 1: schematic representation of four eukaryotic cell cycle phases with a subdivision 
of mitotic phase. Three major cell cycle checkpoints are depicted as red wedges.  
 
1.1. CELL CYCLE CHECKPOINTS 
During the progression of the cell cycle, the cell must go through crucial decision moments, 
where its inner control mechanisms decide whether to commit to the progression of the cell cycle 
or to bail out for safety reasons. Throughout the cycle there are three such cell cycle checkpoints 
[Johnson and Walker, 1999, Kastan and Bartek, 2004]. Restriction checkpoint represents the first 
and major checkpoint. Occurring in a late G1 phase, just before entering the S phase this 
checkpoint is responsible for checking external stimuli, level of growth factors, DNA damage, and 
steady rate of protein synthesis. Once a cell passes through the restriction point it is fully committed 
to going through the cell cycle [Johnson and Skotheim, 2013]. The second checkpoint happens in 
the G2 phase and this time it specializes in scanning for DNA damage. Freshly duplicated DNA 
molecules are scanned for any sites of damage, lesions, or portions with incomplete replication. 
Similar to the restriction checkpoint, information about severe DNA damage is transferred 
downstream by a network of kinases, most important of which are Ataxia Telangiectasia and Rad3 
related (ATR) kinase, Ataxia Telangiectasia Mutated (ATM) kinase, Checkpoint kinase 1 (CHK1), 
and Checkpoint kinase 2 (CHK2) and kinase targets like cell division cycle 25 (CDC25) or Polo-
Like Kinase 1 (PLK1). Signaling through this network leads to an arrest in G2 with the cycle delayed 
until the damage is repaired [Bassermann et al., 2008]. The last important checkpoint takes place 
in the metaphase of a mitotic M phase and controls for proper alignment of a mitotic spindle, the 
correct position of all chromosomes, and adequate tension along the spindle microtubules. All the 
above-mentioned checkpoints represent pivotal decision moments in the cell cycle, where markers 
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important for non-pathological progression are checked. Once the cell fails the checkpoint, the cell 
cycle is arrested, the level of damage is assessed and the progression is either paused till available 
repair mechanisms fix the acute problem or stopped altogether and the cell is destined to following 
one of the pathways leading toward cell death [Pietenpol and Stewart, 2002].  
1.2. DNA REPLICATION 
DNA replication is a key process in the cell cycle. The whole genetic information of a given 
cell stored in a long, yet fragile DNA molecule must be duplicated flawlessly in this step. Due to 
its size (up to 100 Gb in some plants [Yang et al., 2019]) eukaryotic DNA molecules are replicated 
from thousands of sites at the same time.  Those sites, called origins of replication, are scattered 
along the genome to ensure each part of every chromosome is replicated on time and correctly. In 
fact, there are more replication origins on the DNA molecule than is actually used in the early 
replication stage, but only some of the origins turn to so-called “firing origins” while others remain 
dormant [Heller et al., 2011]. Replication starts already in the late G1 phase with the origin licensing 
step, where the chosen origin is turned on by the formation of the pre-replication complex. This 
process must be tightly regulated to ensure that each part of the DNA molecule is duplicated only 
once during the replication step. The pre-replication complex is formed by sequential recruitment 
of its components starting with the Origin Recognition Complex (ORC), followed by licensing 
factors Cell Division Cycle 6 (CDC6) and Cdc10-Dependent Transcript 1 (CDT1) [Mailand and 
Diffley, 2005], and finished by recruiting a pair of replicative helicases complex MiniChromosome 
Maintenance  2–7 (MCM2-7), oriented in an opposite direction to each other [Remus et al., 2009]. 
The pre-replication complex in this form can then be turned into a pre-initiation complex by the 
activity of S phase kinases. Although many origins are licensed, just a few of them are activated, 
with the rest serving as a backup for cases of the stalled replication machinery. Upon origin 
activation, the pair replicative helicase complexes start moving away from each other, thus 
unwinding the DNA and providing a template for the replication machinery [Fragkos et al., 2015].  
The replication machinery, the replisome, presented in figure 2, assembles on the Y-shaped 
structure, opened by the progression of the replicative helicase complex and called the replication 
fork. Replisome assembly follows the origin activation. Additional factors, most important of 
which is the Cell Division Control protein 45 (CDC45), are recruited to the replication fork in a 
process directed by Cell Division Cycle 7/ DumbBell former 4 (CDC7/DBF4) heterodimeric 
kinase and CDK activity [Pacek et al., 2006, Heller et al., 2011]. Upon phosphorylation, replisome 
binds a GINS (from the Japanese Go-Ichi-Ni-San) heterotetrameric complex, tightly associated to 
the first recruited DNA polymerase of the replisome, DNA polymerase ε [Gambus et al., 2009]. 
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At this point, MCM replicative helicase complex encircles both strands of the DNA molecule at 
the origin site. In the following step, helicase must therefore rearrange and wrap only around the 
soon to be leading strand. This step is currently poorly described although it is understood that 
phosphorylation by both CDK and CDC7/DBF4 plays a crucial role [Bruck and Kaplan, 2015]. 
Final activation of the replicative helicase is facilitated by the Minichromosome Maintenance 10 
(MCM10), turning helicase into active CDC45, MCM2-7, GINS (CMG) complex and accompanied 
by the single-strand binding Replication Protein  A (RPA) association with the first appearing naked 
DNA single strand. Movement of the CMG helicase along the leading strand of the nascent 
replication forks generates single-stranded DNA (ssDNA) which is immediately decorated with 
RPA [Kanke et al., 2012], providing sites for priming by the DNA polymerase α (Pol α)–DNA 
primase complex for leading strand DNA synthesis. Primase then synthesizes a short RNA primer, 
necessary for the initiation of DNA synthesis [Arezi and Kuchta, 2000]. Primer is recognized by 
DNA polymerase and serves as a starting point for DNA polymerase processive action, copying 
the DNA template by synthesizing a complementary DNA strand. Because the DNA polymerase 
can add nucleotides into the chain only in the 5‘ to 3‘ direction, the replication process must be 
performed in a semidiscontinuous manner. Here, the replicative helicase-bearing leading strand is 
replicated continuously, while the complementary, lagging strand is replicated discontinuously in 
short, about 200 nucleotide fragments called Okazaki fragments which are processed afterward by 
primer degradation, post primer gap filling by dedicated DNA polymerase, and religation by DNA 
ligase [Burgers, 2009, Waga and Stillman, 1994]. DNA molecule often occurs in the super-coiled 
conformation. Such a state, when encountered by the progressing replication fork, generates 
tension in the DNA molecule and resistance for the replisome, which once unresolved, can lead 
even to the stalling of the replication machinery. To counter this problem, topoisomerase, an 
enzyme responsible for the unwinding of the super-coiled structure of the DNA in a single strand 
break mediated catalytic action, cleans the platform for replisome action [Champoux, 2001].  




Figure 2: Organization of eukaryotic cell replication machinery on the replication fork 
structure. Adapted from [O’Donnell and Kurth, 2013] 
 
1.3. REPLICATION STRESS 
To successfully perform the duplication of a complete genetic material of the cell, the 
replication machinery encounters plenty of obstacles of either endogenous or exogenous origin, 
hindering its progress along the DNA molecule. Such obstacles and consequential delays in the 
progression of the replisome collectively contribute to a phenomenon of the so-called replication 
stress. Minor cases of the replication stress can be relieved on the fly by pausing and waiting till the 
obstacle is cleared or by repriming past the lesion. On the other hand, major incidents of replication 
stress, loss of key reparation pathways, or chronic replication stress can lead to severe 
consequences, ranging from checkpoint activation to apoptosis and in cases where the replication 
stress response fails systemically even to several pathologies including malignant transformation 
[Zeman and Cimprich, 2013].  
Sources of the replication stress are not yet fully described, and the portfolio of possible 
causes is continually growing. Missing parts of the DNA molecule, like nicks, gaps, and extended 
single strands are closely connected with the replication stress as they can form both the cause of 
the stress as well as a symptom of resolution in progress. Nick-like structures cause pausing of the 
replisome before them because encounter of those structures with the replication machinery 
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inevitably leads to double-strand breaks [Ciccia and Elledge, 2010]. Closely related are portions of 
DNA molecule possessing complicated and thus stable secondary structure elements, repetitive 
sequences, G-quadruplexes, and other elements intrinsically challenging for the replication 
apparatus. Such sequences must be preprocessed by specialized helicases before the DNA 
replication resumes [Maffia et al., 2020]. Another source of replication stress stems from the fact 
that both the replication machinery and the transcription machinery are working on the same 
template DNA molecule. This inevitably leads to collisions between those two systems or between 
replisome and products of the transcription machinery. RNAses, helicases, topoisomerases, and 
targeted translocation of the gene product through the nuclear pore are utilized to resolve 
replication – transcription conflicts [Bermejo et al., 2012].  
The most common and often severe sources of the replication stress origin in the unrepaired 
structural DNA damage, known as DNA lesions. They constitute an unreplicable barrier, 
inaccessible for the replicative DNA polymerase or other components of the replisome, and thus 
cause stalling of the replication fork. Replication blocking lesions can be of both endogenous 
(metabolic reactive oxygen species byproducts, products of histone code remodeling, aberrant 
DNA processing enzymes) and exogenous (biological and environmental toxins, drugs, ionizing 
radiation) origin [Mazouzi et al., 2014]. Common lesions leading to replication stress are intra- and 
more severely inter-strand crosslinks [Ling et al., 2016], and also bulky lesions of protein nature. 
Protein lesions are generating more interest in recent years and it was shown that not only covalent 
adduct-based lesions, termed DNA-Protein Crosslinks (DPC’s) [Duxin et al., 2014] but also 
proteins to tightly yet noncovalently bound to DNA molecule can cause severe problems. One 
such example is protein Ku, which although being a member of different DNA repair pathway, 
once fulfills its function remains stuck in a ring-shaped conformation around the DNA 
double-strand and if unremoved causes the replication stress [van den Boom et al., 2016]. The 
severity of DNA lesions blocking the progression of replisome is corroborated by the fact that cells 
evolved a specialized pathway to counteract most of them. Although less complicated lesions can 
be bypassed by translesion synthesis [Lehmann et al., 2007], more challenging lesions usually lead 
to fork stalling, followed by lesion repair pathway activation and, depending on the result of the 
repair process or time required, either fork restart over repaired lesion or one of the available 
backup mechanisms (repriming, template switching, fork reversal or firing of a nearby dormant 
origin [Cortez, 2015].  
Once the early origins are fired and the cell commits to the replication process, it needs to 
delicately balance fidelity, speed of replisome progression, and consumption and distribution of 
relevant material and metabolic resources needed to keep the replication machinery on track. 
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Therefore, a limited pool of free deoxynucleotide triphosphates (dNTP), insufficient synthesis of 
replication machinery components, or lack of histones available for DNA packaging represent 
another important, yet often overlooked, cause of the replication stress [Bester et al., 2011]. 
Hydroxyurea, an often used antineoplastic drug,  is a prime example of such a mechanism, as it 
inhibits the enzymatic activity of free dNTP-generating enzyme, ribonucleotide reductase, thus 
limiting the pool of free dNTPs and in turn, slowing down the replisome progression, possibly 
even leading to cell cycle arrest in S phase [Petermann et al., 2010].  
To detect and resolve incidents of replication stress cell exploits a network of DNA damage 
sensing kinases. Stalled replication fork often leads to the uncoupling of replicative CGM helicase 
activity from replicative polymerase activity. Helicase progressing further along the leading strand 
thus generates extended patches of RPA decorated single-strand DNA. Such moieties in the 
vicinity of nascent, freshly replicated double-stranded DNA generates a primer-template junction 
signal for activation of the replication stress response.  ATR interacting protein (ATRIP) is then 
recruited to the RPA coated ssDNA patches and brings ATR and ATM kinases. ATR follows by 
phosphorylation of RPA, surrounding histones H2AX and downstream kinase CHK1. Signaling 
via ATR and its downstream factors leads to inhibition of cell cycle progression, fork stabilization, 
inhibition of late origin firing, inhibition of recombination, and initiation of repair of the replication 
block or repair of the faulty replication fork. Once the obstacle is removed, the replisome can be 
restarted [Yamada et al., 2013, Tkach et al., 2012].  
1.4. ROLE OF PROTEOLYTIC ENZYMES IN REPLICATION STRESS 
RESPONSE 
As many of the factors constituting replisome as well as other molecular machines working 
on the DNA molecule are proteins, it comes as no surprise that proteases, enzymes responsible for 
degradative or regulatory cleavage of proteins and polypeptide chains, represent an important 
group of players involved in DNA replication stress response [Barker et al., 2005]. Two types of 
proteolysis participating in the replication stress response can be distinguished. Indirect proteolysis 
involves cleavage of regulation factors and effectors or no longer needed components of replication 
machinery by regulatory proteases, often in a ubiquitin-dependent manner. Proteins causing 
replication blocking lesions could be cleaved by indirect proteolysis as well, but they require prior 
labeling and translocation. The other type of proteolysis involved, direct proteolysis, occurs in situ, 
on the DNA bound stalled replication fork. Here, the acting protease cleaves the lesion-causing 
protein component of DPC, protein noncovalently but tightly interacting with DNA strand and 
thus blocking replication or inhibitory inner component of replisome directly in the actual site of 
the collision.  
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Roles of indirect proteolysis processes in replication stress response are more studied and 
thus well established. The Ubiquitin-Proteasome System (UPS) is the key player here, participating 
in multiple proteolytic events. In addition to the timely degradation of cyclins and other molecules 
needed for the accurate onset and progression of the replication process, proteasome also directly 
participates in signaling networks mediating the replication stress response [Garcia-Rodriguez et al., 
2016]. Particularly, it is responsible for the degradation of CHK1 kinase in both ATR 
phosphorylation and ubiquitination dependent manner. Degradation of phosphorylation-activated 
CHK1 may promote checkpoint termination to limit the duration of CHK1 signaling during 
low-intensity replication stress [Zhang et al., 2005]. RNA Polymerase II (RNAP II) represents 
another target of UPS in the replication stress response. RNAPII stalled at a DNA lesion blocks 
progression of the replisome and triggers a coordinated rescue mechanism that requires 
ubiquitylation and degradation of RNAPII [Woudstra et al., 2002]. Lastly, even proteins serving as 
facilitators of DNA repair could turn into replication stress-causing obstacles. Double-strand break 
repair protein Ku80 facilitates the nonhomologous end-joining repair mechanism of the 
double-strand break. Owing to its mechanism of action and sterical properties, some of the Ku80 
molecules end up trapped around the now-repaired molecule of DNA in a ring-shaped 
conformation. Such a repair pathway byproduct represents an obstacle for progressing replisome 
and must, therefore, be removed. The clearance of trapped Ku80 is mediated by K48-linked 
polyubiquitination, followed by the recruitment of Valosin-Containing Protein/protein 97 
(VCP/p97). Translocase p97 then unfolds the trapped protein and extracts it from the chromatin 
in an ATP-dependent manner. The whole process is finished by proteasome-mediated degradation 
of polyubiquitinated Ku80 [van den Boom et al., 2016].  
1.5. DIRECT PROTEOLYSIS IN REPLICATION STRESS RESPONSE 
In addition to the common and well-studied indirect cellular proteolytic response to 
replication stress, new proteases, which seem to be acting in parallel with the above mentioned 
proteolytic pathways, have been recently identified. Unlike the regulatory proteases, those new 
proteases act through direct proteolysis of proteins blocking the replication fork. In general, there 
is not much known about those proteolytic events nor their regulation, yet. Few substrates are 
known, mainly stemming from replication fork progression blocking lesions of protein nature, such 
as enzymes operating on DNA strand, other proteins covalently crosslinked to DNA, or replication 
regulating factors blocking restart of a paused fork.  
Currently, there are three groups of proteases known for the direct proteolytic response to 
replication stress. Metalloproteases of the WSS1/Spartan family were the first identified [Stingele 
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et al., 2014]. The second group of proteases involved is the Ddi1-like family of aspartic proteases 
[Kottemann et al., 2018]. Surprisingly, recent literature shows that, in addition to its regulatory 
proteolysis role, 26S proteasome can be recruited directly to sites of DPC lesions and utilized as a 
DPC protease [Larsen et al., 2019].  
1.5.1. DNA dependent metalloproteases 
The first protease identified as participating in the direct proteolysis in response to replication 
stress was the S. cerevisiae Wss1p protein [Stingele et al., 2014].  First identified as a Weak Suppressor 
of Smt3 (WSS1), Wss1p is a 296 amino acid long protein belonging to the minigluzincin group of 
zinc endometalloproteases [Biggins et al., 2001]. Structurally, Wss1p possesses a multidomain 
architecture with a major part of the N-terminal half of the protein occupied by the metalloprotease 
domain. C-terminal half of the protein consists of various interaction-mediating domains and 
motifs with a major part harbouring a domain responsible for DNA binding, flanked by two 
peptide motifs recruiting Cell division control 48 protein (Cdc48p) ATPase/translocase (SHP and 
VCP-interacting motif (VIM)). The very C-terminus then provides two peptidic SUMO Interacting 
Motifs (SIMs), SIM1 and SIM2, binding to the Small Ubiquitin-like MOdifier (SUMO) Smt3p, or 
SUMO chains [Stingele et al., 2014]. A detailed three-dimensional structure of the Wss1p protease 
domain, shown in figure 3, was solved and provides molecular details pointing to the catalytic 
mechanism of the enzyme. Central to the structure is a canonical zinc-binding motif of 
minigluzincin family of proteases H-E-X-X-H at the catalytic center conserved among all 
orthologues. The glutamate residue E116 serves as a proton shuttle in the proteolytic reaction and 
its mutation to glutamine renders the protein catalytically inactive [Yang et al., 2017].  




Figure 3: Structure of Wss1p/SPRTN proteins. A) 3D structure of S.cerevisiae Wss1p WLM 
protease domain. Detailed organization of the active site with Zinc ion coordinated by 
histidines and proton shuttling catalytic glutamate E116 shown in the inset. Adapted from 
PDB structure 5XBN [Yang et al., 2017]. B) Schematic depiction of domain organization in 
S.cerevisiae Wss1p and human SPRTN proteins. 
 
High throughput genetic analysis repeatedly identified the gene encoding WSS1 protease as 
being important for resistance to various stress-inducing factors, mainly those targeting DNA and 
cellular processes involving DNA [Pan et al., 2006, Bialkowska and Kurlandzka, 2002, Birrell et al., 
2001]. The more targeted analysis revealed WSS1 participation in stabilization or processing of a 
stalled replication fork, where it collaborates with the DNA damage response phosphatase Psy2p 
[O’Neill et al., 2004]. Interestingly, Wss1p is localized only in one sharp spot close to the nuclear 
membrane. In dividing budding cells this localization is exclusive to the mother cell [van Heusden 
and Steensma, 2008]. The role of WSS1 in the sumoylation/desumoylation network remains 
unclear. Although Wss1p must be connected to Smt3p-based transactions in a cell as its 
overexpression was identified as suppressing phenotypes of temperature-sensitive mutants in the 
SMT3 gene [Biggins et al., 2001] and the protein itself harbours two SIMs, experimental evidence 
for the molecular mechanism remains highly conflicting. There is a publication by Mullen and 
colleagues suggesting Wss1p acts as a desumoylase [Mullen et al., 2011, Mullen et al., 2010], but 
other authors studies failed to replicate such activity [Stingele et al., 2014]. Balakirev and colleagues, 
on the other hand, suggest a balanced WSS1 dependent mechanism where Wss1p acts even as a 
novel Smt3p ligase and at the same time cleaves oligomeric Smt3p chains but not with a typical 
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desumoylase activity [Balakirev et al., 2015]. Altogether, conclusions about Smt3p-related activity 
of Wss1p are highly conflicting and need to be refined by further research.  
The importance of Wss1p protease for stabilization and rescue of replication fork was 
revealed by Stingele and colleagues. They provided evidence for Wss1p role as a DNA activated 
protease, acting on DNA-protein crosslinks [Stingele et al., 2014]. Here, as it is schematically 
illustrated in figure 4, Wss1p is recruited to the stalled replication fork blocked by a protein lesion 
covalently crosslinked to DNA molecule. Bulky DPC lesion blocks not only polymerase 
progression but the helicase activity as well and the cell, therefore, cannot switch on the ssDNA 
activated ATR-mediated DNA damage signaling. Recruited Wss1p is activated by binding to DNA 
and nonspecifically cleaves and degrades the bulk of the protein portion of the lesion. The small 
peptide lesion crosslinked to DNA left behind no longer blocks the progression of the replicative 
helicase and allows the helicase-polymerase uncoupling and activation of standard ATR mediated 
response to replication stress [Stingele et al., 2014].  
 
 
Figure 4: Schematic representation of Wss1/SPRTN protease-dependent clearance of a 
DNA-protein crosslink lesion in collision with the stalled replication fork.  
 
Nonspecific active protease in the inner space of a replicating cell nucleus presents a 
dangerous double-edged sword and the activity of Wss1p must, therefore, be tightly regulated. 
Under normal conditions, Wss1p is kept at very low abundance in autoinhibited form. Proteolytic 
activity is released by interaction with DNA, particularly ssDNA, with a minimal DNA string length 
of 16 bases needed for activation. An alternative way for activation is provided by interaction with 
the thiol-modifying compound thiram suggesting a cysteine switch mechanism. Clearance of the 
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unnecessary protein, after it releases the replication stress-causing lesion, is mediated by 
autoproteolysis. Another layer of regulation is mediated by Wss1p interactions with Smt3p and 
Cdc48p segregase/translocase as it was demonstrated for cleavage of topoisomerase covalently 
trapped on DNA [Balakirev et al., 2015, Stingele et al., 2014]. 
Recently Madi and colleagues provided evidence that Wss1p not only cleaves protein trapped 
covalently on DNA strand but resolves also replication stress stemming from lack of resources for 
replication. They showed that Wss1p provides tolerance for hydroxyurea induced replication stress 
by the degradation of core histone subunits non-specifically and non-covalently trapped on 
ssDNA. Unlike Wss1p-dependent proteolysis of covalent DNA-protein crosslinks, proteolysis of 
histones does not require Cdc48p nor SUMO-binding activities [Maddi et al., 2020]. 
In mammalian cells, clearance of proteins covalently trapped on DNA is facilitated by a close 
relative of Wss1p protein from the same minigluzincin family of proteases, SprT-like 
domain-containing protease Spartan (SPRTN) [Vaz et al., 2016, Morocz et al., 2017]. SPRTN 
protease shares the zinc endometalloprotease activity but differs slightly in regulation. Although 
the activation by DNA interaction is conserved, SPRTN is autoinhibited by a monoubiquitination 
switch-based system and upon recruitment to the replication fork interacts with the Proliferating 
Cell Nuclear Antigen (PCNA) complex and moves along the leading strand together with PCNA 
[Li et al., 2019, Wang et al., 2016, Stingele et al., 2016]. Deficiencies in SPRTN manifest clinically 
in progeroid phenotypes and increased tumorigenesis [Lessel et al., 2014, Maskey et al., 2014, 
Lopez-Mosqueda et al., 2016]. 
1.5.2. Ddi1-like aspartic proteases 
Ddi1-like proteases form a group of aspartic proteases. The first described member of this 
family was Ddi1p protein from buddying yeast S. cerevisiae. Ddi1p is a multidomain protein with 
various described functions inside a cell. Therefore, it comes as no surprise that this protein was 
first characterized on two independent occasions. First, it was described as a gene product induced 
by DNA damaging chemicals and named DDI1 – DNA damage-inducible 1 [Liu and Xiao, 1997]. 
One year later, another group of researchers identified this protein as a regulator of SNARE 
proteins in vesicular transport and named it Vsm1p – vSNARE master 1 [Lustgarten and Gerst, 
1999]. Although it may lead to confusion in early literature, both those names refer to the same 
protein, 428 amino acid long, harbouring multidomain architecture, containing N-terminal 
UBiquitin-Like (UBL), C-terminal UBiquitin Associated (UBA) domains, with a characteristic 
RetroViral aspartic Protease-like (RVP) domain in the middle [Sirkis et al., 2006]. RVP domain 
provides a dimerization interface and all Ddi1-like proteins homodimerize via RVP, forming a fold 
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structurally resembling proteases from retroviruses such as Human Immunodeficiency Virus (HIV) 
[Kumar and Suguna, 2018]. Structural features of Ddi1-like proteins, together with characteristic 
domain composition are shown in the figure 5. Ddi1-like proteins are conserved throughout the 
eukaryotic organisms, with RVP aspartic protease domain being the most conserved part 
throughout species [Krylov and Koonin, 2001].  
 
 
Figure 5: Structural features of Ddi1-like family of proteins. A) 3D structure of S.cerevisiae 
UBL domain adapted from PDB entry 2MRP [Nowicka et al., 2015]. B) 3D structure of 
S.cerevisiae RVP domain with highlighted catalytic aspartates Asp220, adapted from PDB 
entry 2I1A [Sirkis et al., 2006]. C) 3D structure of S.cerevisiae UBA adapted from PDB entry 
2MR9 [Nowicka et al., 2015]. D) Schematic depiction of domain organization in S.cerevisiae 
Ddi1p and human DDI1 and DDI2 proteins with highlighted catalytic aspartates. 
 
1.5.2.1. Yeast Ddi1 
In S. cerevisiae, the single exon gene YER143w encoding Ddi1p protein is located on 
chromosome V. Product of the DDI1 gene is transcribed from the bidirectional promoter shared 
with MAG1, 3-methyl adenine DNA glycosylase, the first enzyme involved in base excision repair 
pathway. Expression of both DDI1 and MAG1 is inducible by alkylating chemicals and other 
agents damaging DNA such as hydroxyurea, 4-nitroquinoline 1-oxide, or ultraviolet (UV) radiation 
[Liu and Xiao, 1997, Liu et al., 1997], but unlike MAG1, DDI1 expression inducibility is regulated 
not only by Radiation sensitive 53 (RAD53) kinase dependent S-phase DNA damage checkpoint 
pathway but by Precocious Dissociation of Sisters 1 (PDS1) securin dependent DNA damage 
checkpoint pathway as well [Zhu and Xiao, 1998]. Overexpression of DDI1 leads to dosage 
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suppression of pds1-128 temperature-sensitive defect, specifically in the S-phase checkpoint 
pathway [Clarke et al., 2001]. Expression and inducibility of both DDI1 and MAG1 are directly 
controlled by the Pleiotropic Drug Resistance 3 (Pdr3p) transcriptional activator and indirectly 
affected by Rpn4p (Regulatory Particle Non-ATPase), a transcription factor for proteasome 
subunits [Zhu and Xiao, 2004] and Rad6p-Rad18p ubiquitination complex [Fu et al., 2008].  
In addition to DNA damage inducibility, DDI1 also acts as a negative regulator of 
constitutive exocytosis. It was identified in a yeast two-hybrid screen for Snc1p (Suppressor of the 
null allele of CAP) vesicle membrane receptor (vSNARE) regulators and deletion yeast strain 
lacking DDI1 displayed an increased level of constitutive exocytosis, whereas DDI1 overexpression 
led to decreased exocytosis [Lustgarten and Gerst, 1999]. Mechanistically Ddi1p interacts with 
target membrane receptor (tSNARE) protein Sso1p (Supressor of Sec One 1), thus blocking Sso1p-
Sec9p (SECretory 9) interaction and formation of the tSNARE complex. Ddi1p-Sso1p interaction 
is a stoichiometric inhibitory interaction, independent of the Ddi1p UBA domain, and does not 
lead to Sso1p degradation [Marash and Gerst, 2003]. Ddi1p binds to Sso1p via amino acids 344 – 
395, located between RVP and UBL domains, and phosphorylation of both proteins is important 
for the interaction [Gabriely et al., 2008]. The role of the catalytic activity of the RVP domain in 
this process was suggested as well [White et al., 2011a]. Recently, DDI1 was found to have a role 
in Guanine nucleotide-binding protein Gpa1p (G Protein Alpha subunit 1) [Dixit et al., 2014] 
endocytosis and in selective anterograde transport of Cps1p (CarboxyPeptidase yscS 1) 
carboxypeptidase oligomers into endosomal multivesicular bodies [Kama et al., 2018]. Unlike in 
exocytosis regulation, here the Ddi1p function depends on its UBA domain and its interaction with 
a monoubiquitinylated partner.  
The best-described function of yeast DDI1 is its action in the delivery of polyubiquitinylated 
substrates to the proteasome, acting as a so-called proteasomal shuttling protein. Proteasomal 
shuttling proteins form a group of UBL and UBA domain-containing proteins and besides DDI1 
is represented by RADiation sensitive 23 (RAD23) and DSK2 in yeast. C-terminal or internal UBA 
domain of shuttling proteins interacts with a polyubiquitin chain on substrate destined to 
proteasomal degradation and shuttling protein brings such substrate to the 26S proteasome 
complex. Here, the UBL domain of shuttling protein binds to one of the ubiquitin/UBL binding 
subunits on proteasome 19S regulatory particle, and the substrate is deubiquitinlylated, translocated 
to 20S proteasome catalytic particle and degraded. Shuttling protein is then released and recycled. 
Shuttling of specific polyubiquitinylated targets to proteasome adds another level of control to this 
pathway of regulatory proteolysis [Elsasser and Finley, 2005]. Affinity in all the above-mentioned 
interactions, together with the total amount of shuttling protein must be very fine-tuned in a cell. 
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High levels of proteasome shuttling protein can lead to the stabilization of ubiquitinylated 
substrates, due to masking of polyubiquitin chain by one fraction of shuttle protein and blocking 
proteasome recognition sites by the other, leading to UPS inhibition [Verma et al., 2004].  
Saccharomyces cerevisiae Ddi1p fulfills all criteria for proteasome shuttling protein. UBA of 
Ddi1p was shown to bind both monoubiquitin and polyubiquitin chains, with a slight preference 
for lysine 48-linked chains [Bertolaet et al., 2001b, Saeki et al., 2002, Trempe et al., 2005, Nowicka 
et al., 2015]. The presence of the UBA domain stabilizes Ddi1p in yeast cell by protecting itself 
from proteasomal degradation [Heessen et al., 2005]. UBL domain binds to proteasome via an 
unconventional recognition site on the Regulatory particle non-ATPase 1 (Rpn1p) proteasome 
subunit [Saeki et al., 2002, Gomez et al., 2011]. Surprisingly, a recent study identified UBL of Ddi1p 
not only as an interaction partner for proteasome but also as an unconventional binder of ubiquitin. 
Here, UBL binds to ubiquitin cooperatively via a hydrophobic patch in the β-sheet area and via 
unconventional surface electrostatics, different from other UBLs in proteasome shuttling proteins 
and the Ddi1p UBL-ubiquitin interaction is strong enough for immobilized UBL to pull a fraction 
of polyubiquitinylated protein from yeast cell lysate [Nowicka et al., 2015]. Unlike Rad23p, Ddi1p 
does not facilitate degradation of artificial Ubiquitin Fusion Degradation (UFD) substrate, although 
it can be forced to do so by manipulating Ufd2p ubiquitin E4 ligase to recruit Ddi1p to this 
ubiquitin ligase complex [Kim et al., 2004]. Moreover, DDI1 is partially functionally redundant with 
RAD23 [Diaz-Martinez et al., 2006] and heterodimerizes with Rad23p via their UBL, UBA 
domains [Bertolaet et al., 2001a]. Ddi1p-Rad23p interaction does not inhibit ubiquitin recognition 
by either of the interacting proteins. On the contrary, heterodimerization facilitates the formation 
of the Ddi1p-Rad23p-K48-linked tetraubiquitin chain trimeric complex in vitro, with a suggested 
role in blocking unnecessary additional ubiquitination or preventing deubiquitination while 
transporting substrate to the proteasome. Simultaneous deletion of DDI1 and RAD23 leads to the 
accumulation of polyubiquitinylated proteins in the cell [Kang et al., 2006].  
Known substrate repertoire, targeted by Ddi1p for proteasomal degradation, consists of 
two proteins, HOmothallic switching (HO) endonuclease, and F-box protein Ufo1p 
(UV-F-box-HO 1). Both substrates are involved in the DNA damage response. HO endonuclease 
initiates the yeast mating-type switch process by creating a DNA double-strand break at the MAT 
locus. The presence of active HO endonuclease inside a cell nucleus is tightly regulated, with 
expression restricted to mother cells in the late G1 cell cycle phase, once a cell is committed to the 
following duplication. Its cellular halftime is around 10 minutes under native conditions, where, 
after endonuclease cleavage, HO endonuclease is displaced from the nucleus to cytoplasm in a 
MEC1 (Mitosis Entry Checkpoint 1) mediated manner, ubiquitinylated by multiprotein SCF 
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(Skp1–Cullin–F-box-protein) ubiquitin E3 ligase complex and degraded by the proteasome. Ddi1p 
was shown to copurify with polyubiquitinylated HO endonuclease via its UBA domain, whereas 
the UBL domain of Ddi1p is required for HO binding to proteasomal Rpn1p subunit. The deletion 
of the DDI1 gene leads to the accumulation of undegraded polyubiquitinated HO endonuclease in 
the cytoplasm [Kaplun et al., 2005]. The second substrate targeted by Ddi1p, F-box protein Ufo1p, 
is actually a F-box part of the multiprotein SCF E3 ubiquitin ligase complex, responsible for HO 
endonuclease ubiquitination. Ufo1p is an unusual F-box protein, involved in DNA damage 
response, which contains four copies of C-terminal ubiquitin interacting motifs (UIM), short helical 
peptide sequences known to bind ubiquitin. Although the UFO1 deletion strain is viable, deleting 
only the UIM part of UFO1 leads to a dominant-negative lethality. Ectopic overexpression of 
UFO1 without UIMs brings cell to G1/S arrest with a morphology dominated by long, extended 
buds, a phenotype similar to a temperature-sensitive mutant of SKP1 (Suppressor of Kinetochore 
Protein mutant 1) member of SCF complex at the restrictive temperature. The same phenotype 
can be observed upon overexpression of full-length UFO1 in yeast strain with deleted DDI1 
[Ivantsiv et al., 2006]. Ddi1p UBL interacts with Ufo1p via those UIM motifs and facilitates Ufo1p 
proteasome-mediated degradation. When not degraded, Ufo1p blocks an F-box exchange-driven 
recycling of the SCF E3 complex, causing cell cycle arrest [Kaplun et al., 2006]. Interaction between 
Ufo1p, HO endonuclease, and Ddi1p was confirmed by in vitro reconstitution of the complex 
[Voloshin et al., 2012].  
Another cell cycle-related phenotype of DDI1 is suppression of temperature-sensitive 
mutant pds1-128 in PDS1 securin by overexpression of DDI1 (as well as by overexpression of 
RAD23). Pds1p securin is a separase inhibitor with a role in three cell cycle checkpoints, spindle 
assembly checkpoint, DNA damage checkpoint, and DNA replication checkpoint. DDI1 role in 
pds1-128 suppression is limited to the PDS1 role in DNA replication checkpoint [Clarke et al., 2001] 
and is dependent on Ddi1p UBA and UBL domains [Gabriely et al., 2008]. Interestingly, unlike 
pds1-128 mutant, the full deletion of the PDS1 gene can be rescued by neither DDI1 nor RAD23 
overexpression. This observation suggests a requirement for some form of Pds1p, although mutant 
one, for cell cycle progression, thus pointing toward the role of UBL-UBA proteins in the 
stabilization of Pds1p rather than facilitating its degradation. Double deletion of both DDI1 and 
RAD23 genes leads to increased sensitivity to hydroxyurea, as does, although to a lesser extent, the 
deletion of both UBA domains only [Clarke et al., 2001]. The functional importance and 
stabilization effect of yeast Ddi1p UBA domain is highlighted by its targeting by yeast metacaspase 
upon glucose treatment after nutrient starvation which leads to UBA cleavage followed by Ddi1p 
proteolytic degradation [Bouvier et al., 2018].  
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1.5.2.2. Ddi1-like proteins in other eukaryotes 
Functions of the Ddi1-like family of proteins were investigated in other eukaryotic model 
organisms as well, with human Ddi1-like proteins, especially human DNA Damage-Inducible 1 
Homologue 2 (DDI2) being the most extensively studied. As mentioned above, Ddi1-like proteins 
are conserved throughout eukaryotes, although some changes on the domain level can be traced 
through eukaryotic evolution. Plants and fungi in general follow the S. cerevisiae domain architecture, 
although for example S. pombe apparently lost the UBL domain. In animals, the tree domain 
architecture known from S. cerevisiae is retained up to Chordata. Gene duplication from 
retrotransposition event apparently occurred in Chordata common ancestor, resulting in two 
homologues of Ddi1-like family genes present in their genomes. The original one was named DDI2, 
whereas the probably retrotransposed single-exon gene was named DNA Damage-Inducible 1 
Homologue 1 (DDI1). Ddi1-like proteins in Chordata also lost their UBA domains, which probably 
migrated, via an insertion event, to RSC1A1 (Regulator of Solute Carriers 1), a gene downstream 
from DDI2. Replacing the UBA domain, a UIM motif on the last helix of Ddi1-like proteins of 
Chordata was predicted.  
Several protozoan Ddi1-like proteins were studied based on observation, that HIV positive 
patients coinfected with a protozoan parasite show improvement in protozoan infection upon 
treatment with HIV protease inhibitor [Lopez-Velez, 2003]. DDI1 is one of only two aspartic 
proteases encoded in genomes of Leishmania genus parasites, the other being a membrane-bound 
extracellular protease of presenilin type. Indeed, HIV protease inhibitors were shown to bind and 
inhibit Leishmania major Ddi1p RVP, although in an indirect, yeast cell-based assay [White et al., 
2011b]. Currently, L. major Ddi1p is the only Ddi1-like protein with in vitro measures enzyme 
activity of a purified protein [Perteguer et al., 2013]. The structure of L. major Ddi1p RVP resembles 
that of yeast and human Ddi1-like RVP domains [Kumar and Suguna, 2018]. Ddi1 proteins from 
other protozoa, namely Plasmodium berghei [Onchieku et al., 2018] and Trypanosoma cruzi [Castilho 
et al., 2018] were studied by homology modeling and in silico inhibitor docking studies with results 
suggesting possible binding of HIV protease inhibitors. 
Drosophila melanogaster Ddi1-like gene, rngo (rings lost), is an essential gene and its disruption 
in the germline leads to sterility due to defects in oogenesis caused by disruption of ring canal 
formation. Interestingly, although Rngo protein was shown to bind ubiquitin as well as proteasome 
subunit Rpn10 (regulatory particle non-ATPase 10), both UBL and UBA domains of Rngo were 
dispensable in the rescue experiment. On the contrary, RVP and also the presence of putative 
catalytic aspartate were essential for ring canal formation rescue [Morawe et al., 2011]. 
D. melanogaster Rngo was also identified in neuron cells as one of the primary targets for 
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nondegradative K48 polyubiquitination by E3 Ubiquitin protein ligase E3A (Ube3a) defective in 
Angelman syndrome [Ramirez et al., 2018]. Ube3a driven Rngo ubiquitylation in D. melanogaster 
neurons is reverted by the Ubiquitin Specific Peptidase 9 X-Linked (USP9X) deubiquitinase [Elu 
et al., 2019].  
Caenorhabditis elegans strains lacking functional ddi-1 display increased synaptic connectivity 
and enhanced synaptic density [Guthmueller et al., 2011]. Moreover, C. elegans ddi-1 is involved in 
the degradation of the SLO-1 BK channel, regulating locomotion, neurotransmitter release, and 
alcohol resistance [Oh et al., 2017]. Under proteasome inhibition or dysfunction, ddi-1 is 
participating in a feedback loop leading to the expression of new proteasome subunits. 
Transcription of proteasome subunits is driven by transcription factor skn-1. Under normal 
conditions, SKN-1 is an endoplasmic reticulum (ER) membrane protein with a very short lifetime. 
After translation, SKN-1 is quickly ubiquitinylated by ER associated degradation (ERAD) ubiquitin 
ligase complex HRD-3 (HMG-coA Reductase Degradation 3), retrotranslocated by Cdc48, 
deglycosylated by Peptide N-Glycanase 1 (PNG-1), and degraded by the proteasome in usual 
ERAD pathway. With proteasome dysfunction, SKN-1 cannot be effectively degraded, 
accumulates, and is cleaved by DDI-1, most probably by the activity of its RVP aspartic protease 
domain. Processed SKN-1 then translocates into the nucleus where it serves as a transcription 
factor driving the expression of several proteasome subunits [Lehrbach and Ruvkun, 2016].  
The identical function of DDI2 protein in the processing of proteasome subunit expression 
regulating transcription factor is conserved in mammals as well. Here, as illustrated in figure 6, 
transcription factor 11/ nuclear factor E2-related factor 1 (TCF11/NRF1) encoded by NFE2L1 
(nuclear factor erythroid-2-like 1) gene is an ER-resident transcription factor that is continually 
retrotranslocated and degraded by the proteasome in ERAD dependent manner. After proteasome 
inhibition, TCF11/NRF1 avoids degradation and is proteolytically processed to its active form by 
DDI2 RVP aspartic protease activity [Koizumi et al., 2016, Nowak et al., 2018]. In addition to 
TCF11/NRF1, human DDI2 activates similarly also homologous transcription factor NRF3 
(nuclear factor E2-related factor 3), involved in the regulation of expression of cell proliferation 
factors [Chowdhury et al., 2017, Bury et al., 2019].  




Figure 6: schematic representation of the TCF11/NRF1 activation mechanism via 
retrotranslocation followed by DDI2 mediated proteolytic cleavage 
 
The most recent addition to the repertoire of mammalian Ddi1-like protein functions closes 
the circle and brings Ddi back to its original identification as DNA damage-inducible protein. 
Kotteman et. al. [Kottemann et al., 2018] identified both human DDI1 and DDI2 as factors 
involved in replication fork restart after encountering obstacles. DDI2 associates with active 
replisome and dual silencing of DDI1 and DDI2 results in increased sensitivity to replication 
blocking drugs hydroxyurea and aphidicolin. Based on proteomic data DDI1/2 seems to be 
removing replication termination factor 2 (RTF2) from stalled replication forks in a proposed 
proteasome shuttling mechanism and thus facilitating replication fork restart. RTF2 stabilization 
by dual DDI1/DDI2 depletion leads to impaired recovery from replication stress, accompanied 
by ssDNA accumulation, ATR kinase activation, and increased genome instability [Kottemann 
et al., 2018].  
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2. AIMS OF THE STUDY 
The main aim of this doctoral thesis was to elucidate a physiological function of a Ddi1-like 
class of proteases with a special focus on response to DNA replication stress, using molecular 
biology as well as biophysics.  
Specific aims were:  
1. To biophysically and structurally characterize human DDI2 protein, solve structures 
of its isolated domains, test in vitro proteolytic activity of its protease domain, and 
characterize DDI2 interaction with ubiquitin. 
2. To biophysically and structurally characterize the Ddi1p protein of S. cerevisiae, solve 
the structure of its isolated domains, test in vitro proteolytic activity of its protease 
domain, and characterize yeast Ddi1p interaction with ubiquitin.  
3. To characterize a biological function of the Ddi1p protein of S. cerevisiae in replication 
stress response, with a special focus on the role of its individual domains in this 
process.  
Various biophysical techniques including nuclear magnetic resonance NMR, isothermal 
titration calorimetry, and mass spectrometry, together with molecular biology methods of classical 
yeast genetics and complementation were used as principle tools.  
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3. METHODS 
This chapter highlights only methods important for understanding the results described 
below. Detailed methods for all experiments performed are part of respective publications.  
3.1. PROTEOMIC IDENTIFICATION OF CLEAVAGE SITES (PICS) 
PICS was performed according to the previously published protocol [Schilling et al., 2011] 
with several modifications. Non-transfected cell cultures of either mammalian HEK293 cells or 
yeast Saccharomyces cerevisiae were grown under standard conditions, harvested, and washed with 
phosphate buffer saline (PBS). Cells were transferred into a hypotonic lysis buffer containing 
protease inhibitors and lysed by sonication (HEK293) or multiple passes through Emulsiflex high-
pressure homogenizer (yeast cells), followed by cysteine reduction and alkylation. Proteins were 
precipitated using trichloroacetic acid and resolubilized into 200 mM HEPES, pH 7.5. Following 
resolubilization, the proteome-derived peptide library was prepared by cleaving isolated denatured 
proteins into peptides with a working protease (trypsin or GluC). After abolishing working protease 
activity using 1 mM PMSF, the second round of sulfhydryl reduction and alkylation was performed. 
Primary amines on peptide N-termini and lysine side chains were blocked by formaldehyde-
cyanoborohydride reductive dimethylation. Unreacted or quenched modification reagents were 
removed by gel filtration, and the peptide library was purified and transferred to High Performance 
Liquid Chromatography (HPLC)-grade water using a C-18 solid-phase extraction cartridge. The 
peptide concentration was adjusted to 2 mg/ml. The integrity of the peptide library was confirmed 
by LC-MS/MS analysis, and aliquots were stored at −80 °C until further use.  
For the PICS assay, the peptide library (final concentration 1 mg/ml) was incubated in 200 
μl of the appropriate buffer with 4 μg of an assayed enzyme. The reaction was incubated for 12 h 
at 37 °C. Following incubation, the reaction was heat-inactivated for 30 min at 70 °C and titrated 
with 2 M HEPES, pH 8.5, to final pH 8.0.  
Subsequently, newly formed primary amine groups (products of proteolytic cleavage) were 
biotinylated in vitro by the addition of sulfo-NHS-SS-biotin for 4 h at room temperature. 
Biotinylated products were then immobilized on streptavidin-agarose with mild agitation at room 
temperature, followed by washing. Additional washing steps (2 M urea followed by 20% isopropyl 
alcohol, 5% DMSO, and 5% acetonitrile, all in washing buffer (50 mM HEPES, 150 mM NaCl, 
pH 7.5)) were added to the original protocol, followed by 10 washes with washing buffer. 
Immobilized peptides were eluted with 20 mM DTT, desalted using C-18 reverse phase cartridges 
according to the manufacturer's protocol, and analyzed by mass spectrometry (MS).  
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As negative controls, catalytic aspartate mutants (yeast D220A and human D252A)  and 
buffer alone (blank) were used. As positive controls, the HIV-1 protease cleavage profile in 100 
mM sodium acetate, 300 mm NaCl, pH 4.7, was tested with wild-type and HIV-1(D25N) protease. 
The protease library ratio was 1:200, and the final enzyme concentration was 0.2 μM.  
3.1.1. PICS data analysis 
PICS data were analyzed using a series of predesigned queries in Microsoft Access database 
software. First, lists of identified peptides from each mass MS run were loaded into the database 
and filtered for peptides containing products of N-terminal modification by biotinylation. Second, 
peptides with confidence over 80% were picked for enzymatic reactions (active Ddi1-like protein 
or HIV-1 protease), whereas peptides with confidence over 10% were picked for control reactions 
(reactions with catalytically ineffective forms of the enzymes and blanks). To properly subtract the 
background signal, the list of peptides found in each enzymatic reaction was screened for peptides 
present in the blank reaction and the reaction with the catalytically ineffective enzyme. Such 
peptides were then removed from processing. Finally, the enzymatic reactions were screened for 
peptides identified in the original unprocessed peptide library. Such peptides were also removed 
from the analysis.  
The final cleared list of identified peptides was then mapped against the FASTA database 
used for proteomics database search. By alignment of identified peptides with the database, the 
N-terminal portions of cleaved peptides (preceding the cleavage site) were determined. If there was 
more than one computationally identified amino acid for a given P position, the position was 
omitted from the processing, whereas the rest of the identified peptide sequence remained listed 
for downstream analysis. The final list of substrate peptides containing sequences of five P′ amino 
acids identified in the MS experiment and five P amino acids identified computationally was then 
created. The frequency of each amino acid in each position was then calculated and plotted, yielding 
a substrate specificity matrix for the assayed enzyme.  
3.2. YEAST MANIPULATION 
3.2.1. Yeast strains, growth conditions, and yeast plasmids 
construction 
All Saccharomyces cerevisiae strains used were isogenic derivatives of strain S288C, in the Y7092 
background (MATα can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0 his3Δ1 met15Δ0), and were 
obtained as a gift from professor Charles Boone (Donnelly Centre, University of Toronto). 
Standard yeast YPD (1% yeast extract, 2% peptone, 2% glucose) and synthetic complete (SC)  or 
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SC dropout media were used [Sherman, 2002]. For solid media, 1.5% agar was added. All 
cultivations were performed at 30 °C unless explicitly stated otherwise; liquid cultures were 
incubated at 260 RPM in an orbital shaker. 
Plasmids used for functional complementation experiments were derivatives of the 
centromere bound pAG416GPD-ccdB plasmid (Addgene plasmid #14148). Constructs coding 
Ddi1-like homologues were amplified by polymerase chain reaction (PCR) and inserted in the 
pDONR221 entry vector. Point mutated variants were created using Stratagene QuickChange Site-
Directed Mutagenesis Kit, truncated variants were created by the Gibson assembly method. Final 
expression constructs were created by Gateway recombination cloning from pDONR221 to 
pAG416GPD-ccdB. All plasmids were verified by sequencing. Yeast cells were transformed using 
the standard LiAc/PEG3350 protocol.  
3.2.2. Phenotypic characterization 
Phenotypic characterization was performed by dilution spotting assays. Equal amounts of 
exponentially growing cells in dilution series were plated onto solid YPDA media in presence of 
the analyzed DNA damaging or replication blocking agent. Nonsuplemented YPDA solid media 
was used as a control. All spot tests for a given experiment were always plated on one plate. Plates 
were photographed after 60 h of incubation at 30 °C. 
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4.1. PUBLICATION I:  
Human DNA damage-inducible 2 protein is structurally and 
functionally distinct from its yeast ortholog 
 
Sivá M.*, Svoboda M.*, Veverka V., Trempe J.F., HofmannK., Kožíšek M., Hexnerová R., 
Sedlák F., Belza J., Brynda J., Šácha P., Hubálek M., Starková J., Flaisigová I., Konvalinka J., and 
Grantz Šašková K. Human DNA-damage-inducible 2 protein is structurally and functionally 
distinct from its yeast ortholog. Sci Rep. 6, 30443 (2016). 
* Equal contribution.  
My contribution: cloning of ΔUIM and catalytically inactive D252A variants of human 
DDI2; bacterial expression and purification of full length human DDI2 protein, its RVP domain 
and catalytically inactive variants of both; expression and purification of epitope-tagged full-length 
human DDI2 in mammalian cells; enzymatic synthesis of diubiquitin chains, pull-down assays for 
testing human DDI2 – ubiquitin interaction; PICS proteomics screen for substrates of DDI2 
protease activity; BSA cleavage assay; surface electrostatics analysis.  
4.1.1. Motivation of the study 
Ddi1-like proteins are highly conserved through all eukaryotic organisms. Yeast and human 
Ddi-1 like homologues share a 30 % identity on the sequence level (56 % in the protease domain) 
and similar domain composition can be found in all eukaryotes. Although there is a substantial 
body of experimental work done on the elucidation of DDI1 function in yeast Saccharomyces cerevisiae, 
both Ddi1-like proteins coded in the human genome (DDI2 and its homologue, DDI2) were 
understudied and their structure and function remained elusive.  
The main goal of this study was to investigate the overall structure of human DDI2 protein, 
and detail structural features of its individual domains. Structural studies were followed by 
functional analysis of full-length protein and its isolated domains, with a special focus on putative 
catalytic activity and substrate profile of the RVP domain as well as on potential interactions with 
ubiquitin and other components of the ubiquitin-proteasome system. By shedding some light on 
human DDI2 structural and biophysical characteristics, we wanted to establish a stepping-stone 
for further studies of human DDI2 function in the biological processes in the context of the cell 
and the whole organism.  
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4.1.2. The surface electrostatic potential of the human DDI2 UBL domain 
differs from its yeast homologue 
As Ddi1-like proteins in Vertebrata lost the C-terminal UBA domain to a RSC1A1 gene, via 
an insertion event, a question arises, whether these proteins retained the ability to interact with 
ubiquitin. We did run a bioinformatical analysis and identified a peptidic UIM in the human DDI2 
sequence. This motif showed weak but specific interaction with ubiquitin in nuclear magnetic 
resonance (NMR) experiments. New, unorthodox ubiquitin-binding moiety was recently identified 
in yeast Ddi1p [Nowicka et al., 2015]. In addition to ubiquitin binding via the canonical UBA 
domain, the UBL domain of yeast Ddi1p binds ubiquitin as well. Although the overall folds of 
UBL domain and ubiquitin molecule are similar, the surface charge distribution is almost inverted, 
and therefore yeast UBL and ubiquitin can interact via electrostatic interaction. To test whether 
this interaction exists for the human DDI2 UBL domain as well, we performed an NMR titration 
experiment with human DDI2 UBL titrated by ubiquitin and a parallel experiment where ubiquitin 
was titrated by human DDI2 protein lacking C-terminal UIM. Both experiments showed weak 
interaction in the millimolar range. To address this discrepancy between human and yeast UBLs 
we solved the solution structure of human DDI2 UBL using NMR (figure 7A) (Structure was 
solved and titration experiments were performed by Dr. Monika Sivá). In the following evaluation 
of the structure, I analyzed the surface electrostatic potential distribution using PDB2PQR and 
Adaptive Poisson Boltzmann Solver. As can be seen from figure 7B and 7C, although the secondary 
and tertiary structures of human and yeast UBLs are very close, the distribution of surface 
electrostatic potential differs, with yeast Ddi1p UBL surface being significantly more negative. Due 
to a strong positive charge on the ubiquitin surface (figure 7D) and the electrostatic nature of the 
interaction, the different surface electrostatic potential distribution could explain weaker 




Figure 7: Solution structure of the human DDI2 UBL domain. A) Superimposition of 40 
converged structures of the UBL domain. Comparison of the surface electrostatic potential 
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of B) human DDI2, C) yeast Ddi1p UBL (Publication II) and D) ubiquitin (from PDB 
code 1UBQ). All molecules are oriented based on secondary structure alignment, with the 
β-sheet area towards the reader. The surface is colored from red (negative values) to blue 
(positive values); the range is ±6 kT/e for all structures. Surface electrostatic potential maps 
were generated using the Adaptive Poisson Boltzmann Solver [Baker et al., 2001] package 
with structure preprocessing using the PDB2PQR tool [Dolinsky et al., 2004]. All 
calculations were performed using the SWANSON force field at pH 7.4; Chimera was used 
for final surface visualization. 
 
4.1.3. DDI2 does not interact with diubiquitins 
Although interaction with monoubiquitin can have biological significance, most of the cell 
regulation involving ubiquitin occurs through ubiquitin chains of various linkage architecture. To 
test whether human DDI2 interacts with polyubiquitin chains, with the potential for avidity 
mediated synergistic interaction strengthening, I performed pull-down experiments with various 
forms of immobilized full-length human DDI2 and diubiquitins of all eight types of covalent 
linkage architecture (Lys6-, Lys11-, Lys27-, Lys29, Lys33-, Lys48-, Lys63-linked and linear). As can 
be seen in figure 8A,B none of the eight used commercially available diubiquitin conjugates 
interacted with neither C-terminally (FLAG) nor N-terminally (FLAG or HA) tagged, resin 
immobilized, human DDI2 full-length variant. The same experiment was repeated also with 
in house synthesized Lys48- and Lys63-linked diubiquitins (figure 9). The data clearly show that 





Figure 8: Polyubiquitin chain binding is not preserved in human DDI2. Western blot 
analysis of pull-down experiments with commercial diubiquitin conjugates of various 
covalent linkage architecture. Human DDI2 with a FLAG tag on either the N- or 
C-terminus (A) or an HA tag on the N-terminus (B) was immobilized on magnetic agarose 
beads. Beads were incubated with the diubiquitin conjugate of given linkage architecture, 
washed, eluted, and analyzed on 18% SDS-PAGE followed by immunoblotting with 
anti-ubiquitin antibody. 
 




Figure 9: Human DDI2 shows no interaction with inhouse prepared diubiquitin chains. 
Western blot analysis of pull-down experiments with Lys48 and Lys63-linked diubiquitin 
conjugates prepared inhouse. Human DDI2 with a FLAG tag on either the N- or 
C-terminus or an HA tag on the N-terminus was immobilized on magnetic agarose beads. 
Beads were incubated with the diubiquitin conjugate of given linkage architecture and 
processed as in figure 8.  
 
4.1.4. The protease domain of human DDI2 is not proteolytically active in 
vitro 
Ddi1-like proteins are highly conserved throughout all eukaryotic organisms. Interestingly, 
the most conserved part across all species is the RVP domain, the putative aspartic protease of the 
retropepsin family. Although RVP could serve only as a homodimerization framework, its high 
level of conservation, as well as a presence of the typical retropepsin catalytic triad DT[S]G in all 
known Ddi1-like proteins, raises a question, whether RVP possesses specific catalytic activity and 
what is the physiological significance of such activity.  
To examine the function of human DDI2 RVP we solved the three-dimensional structure 
of this domain. RVP structure resembles those of retroviral proteases with a C2 symmetrical dimer, 
multiple beta-sheet mediated dimerization interface, flexible beta hairpins, so-called flaps, covering 
active site cavity, and a catalytic triad coordinating water molecule, ready to serve as a nucleophile 
in a proteolytic reaction cycle. RVP structure was solved by Dr. Klára Grantz Šašková. 
With information about structural elements being in place for enzyme catalytic action, 
I established an unbiased proteomic screen for the identification of peptidic substrates of the RVP 
domain based on the PICS (Proteomic Identification of protease Cleavage Sites) method. Peptide 
libraries derived from a mammalian cell culture-expressed proteome were prepared and cleaved 
overnight by E. coli expressed full-length human DDI2, using D252A putative catalytic site mutant 
as a negative control and structurally related HIV protease as a positive control. As can be seen in 
figure 10, I did not observe any peptide cleavage pattern related to DDI2 activity. This experiment 
was repeated with mammalian expressed full-length DDI2 as well as with the RVP domain itself. 
All DDI2 variants were assayed on two different variants of the peptide library (GluC and trypsin 
prepared) at pH 4.0, 5.0, and 7.0. None of these experiments led to protease activity detection.  




Figure 10: PICS results: Heatmap representation of protease substrate profile 
demonstrating the total counts of given amino acids (described by single letter code) per 
particular position (P5−P5´) in peptidic substrates in a HEK293 cell line-derived peptide 
library. The cleaved peptide bond is positioned between P1 and P1´. A) Library cleaved by 
HIV-1 protease (positive control) B) Library cleaved by human DDI2 protein in HEPES 
pH 7.0 (proteolytic activity assay). C) Background profile for the uncleaved library (negative 
control). 
 
Furthermore, I tested human DDI2 for proteolytic activity against potential sole protein 
substrates BSA, HSA, casein, and insulin. Unlike its homologue from Leishmania major, human 
DDI2 did not cleaved any of those protein substrates.     
4.1.5. Conclusion 
In this publication, we reported the first structural and functional analysis of a mammalian 
protein from the Ddi1-like family, human DDI2. We identified two previously unknown structural 
elements in DDI2, C-terminal UIM, and Helical Domain of Ddi1-like proteins  (HDD) located 
between UBL and RVP domains. We solved the X-ray structure of the DDI2 RVP domain and 
solution NMR structures of the HDD domain and the UBL domain. Using NMR titrations we 
identified weak but specific interaction between human DDI2 and ubiquitin, mediated by both 
UIM and UBL domains of DDI2. The surface electrostatic potential analysis showed that the 
considerably weaker UBL-ubiquitin interaction, compared to its yeast homologue, could be caused 
by the less negatively charged surface of the human DDI2 UBL. Surprisingly, although human 
DDI2 interacts with monoubiquitin, we did not observe interaction with any of the eight 
diubiquitin covalent isopeptide conjugates. Moreover, we thoroughly studied the RVP domain of 
human DDI2, solved its three-dimensional (3D) structure by protein crystallography, and searched 
for its proteolytic activity. Although we performed an extensive in vitro testing, we did not identify 
any human DDI2 related proteolytic cleavage events.  
  
- 39 - 
 
4.2. PUBLICATION II:  
Structural studies of the yeast DNA damage-inducible protein Ddi1 
reveal domain architecture of this eukaryotic protein family 
 
Trempe J.F., Grantz Šašková K., Sivá M., Ratcliffe C.D.H., Veverka V.,  Hoegl A., Menade M., 
Feng X., Shenker S., Svoboda M., Kožíšek M., Konvalinka J., and Gehring K. Structural studies 
of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic 
protein family. Sci Rep. 6, 33671 (2016). 
My contribution: cloning of ΔUBA and catalytically inactive D220A variants of yeast 
Ddi1p; expression and purification of full-length yeast Ddi1p protein, its RVP domain and 
catalytically inactive variants of both; expression and purification of ΔUBA variant of yeast Ddi1p; 
sample preparation and assistance with ITC measurement; K48-linked diubiquitin synthesis; PICS 
proteomics screen for substrates of Ddi1p protease activity.  
4.2.1. Motivation of the study 
Yeast DDI1 was identified by two independent teams. First, the DDI1 gene was found to 
increase its expression in response to genotoxic agents, with its product involved in the UPS and 
cell cycle regulation. The second independent identification of yeast DDI1 comes, originally under 
the name Vsm1, from its involvement in the regulation of constitutive exocytosis via SNARE 
protein complexes. Interestingly, all known functions of Ddi1p in yeast physiology do require intact 
catalytic active site of the RVP domain, with Asp220 mutations having a detrimental effect. 
Moreover, most of the yeast Ddi1p functions do require at least one member of the 
ubiquitin-related domain pair (UBL or UBA) to be present in the protein sequence.  
Although the requirement for catalytic Asp220 points toward the involvement of RVP 
catalytic activity in yeast physiology, there was no substrate known for the protease domain neither 
in vivo nor in vitro. To decipher the role of yeast Ddi1p proteolytic activity in yeast physiology we 
decided to explore its substrate preference and structural determinants of substrate recognition. 
Moreover, we biophysically analyzed the interaction between yeast Ddi1p and ubiquitin.   
 
4.2.2. The retroviral protease-like domain of yeast Ddi1p does not cleave 
peptide substrates in vitro 
We determined the 3D structure of the retroviral protease-like domain of yeast Ddi1p. Unlike 
earlier structures, our structure contained electron densities for the flexible part of RVP, so-called 
flaps, covering the upper part of the active site. Thanks to specific crystal packing one of the flaps 
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create contacts with the N-terminus of a neighboring molecule and stabilize the N-terminus in the 
active site. This interaction suggests a potential substrate-binding mode for the protease domain of 
yeast Ddi1p. Structural studies were performed by Dr. Jean Francois Trempe.  
To further explore the prospective substrate repertoire of the protease domain, I performed 
the unbiased proteomic assay for the identification of peptidic substrates of the RVP domain based 
on the PICS method. Peptide libraries derived from the expressed proteome of yeast Saccharomyces 
cerevisiae culture in an exponential growth phase were created using trypsin or GluC as preprocessing 
proteases. Libraries were cleaved overnight by E. Coli-expressed full-length yeast Ddi1p, using 
D220A putative catalytic site mutant as a negative control and HIV-1 protease as a positive control. 
As can be seen in figure 11, I did not observe any peptide cleavage pattern related to yeast Ddi1p 
activity. This experiment was repeated with the RVP domain itself. Both yeast Ddi1p variants were 
assayed on two different variants of the peptide library (GluC and trypsin prepared) at pH 4.0, 5.0, 
and 7.0. None of these experiments led to protease activity detection. 
 
 
Figure 11: PICS experiment results. Heat map representation of protease substrate profile 
demonstrating total counts of a given amino acid (in single letter code) per particular 
position (P5−P5´) in a peptidic substrate on Saccharomyces cerevisiae derived peptide library. 
(A) library cleaved by HIV-1 protease (positive control) (B) Library cleaved by yeast Ddi1p 
protein in acetate buffer pH = 4.0 (proteolytic activity assay) (C) background - uncleaved 
library (negative control). The color key is common for all three heat maps. 
 
4.2.3. Ubiquitin binding 
To explore yeast Ddi1p interaction with ubiquitin we performed an isothermal titration 
calorimetry (ITC) experiment, where we titrated full-length yeast Ddi1p by ubiquitin. To our 
surprise, we obtained a stoichiometry ratio of 2:1 for the ubiquitin:full-length yeast Ddi1p 
interaction (figure 12A), although yeast Ddi1p contains only one UBA domain per molecule. 
Indeed, during the preparation of this manuscript, an interaction of ubiquitin with the UBL domain 
of yeast Ddi1p was reported by Nowicka et.al. [Nowicka et al., 2015]. To further elucidate the 
mechanism of ubiquitin - yeast Ddi1p interaction we prepared truncated variants of Ddi1p lacking 
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either UBL or UBA domain. As can be seen in figure 12B and C, both UBL and UBA show 
a stoichiometry of 1:1, with UBA bearing the main part of the total interaction (Kd=43 µM) and 
UBL providing a weaker contribution with a Kd of 310 µM. K48 covalent linkage in diubiquitin 
conjugate potentiates the interaction with full-length Ddi1p with a Kd of 77 μM and a 1:1 




Figure 12: Yeast Ddi1p interacts with ubiquitin. Ubiquitin or K48-linked diubiquitin (Ub2) 
were added by syringe to particular Ddi1p constructs in the sample cell in an ITC titration 
experiment. The different titrations were (A) ubiquitin to full-length yeast Ddi1p, (B) 
ubiquitin to UBL-RVP, (C) ubiquitin to RVP-UBA, and (D) K48-Ub2 to full-length yeast 
Ddi1p. For full-length Ddi1p binding to ubiquitin (A), the dataset was also fitted to a model 
with two independent binding sites (Kd1 and Kd2), each with a stoichiometry of 1. 
 
4.2.4. Conclusion 
In this publication, we investigated the multi-domain structure of yeast Ddi1p using X-ray 
crystallography, NMR, and small-angle X-ray scattering. The crystal structure of the RVP domain 
provides insight into a putative substrate recognition mechanism involving a conserved loop. 
Unlike related retroviral proteases, yeast Ddi1p RVP domain is not capable of cleavage of peptide 
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substrates in vitro. Isothermal titration calorimetry confirmed that both UBL and UBA domains 
bind ubiquitin, and that yeast Ddi1p binds K48-linked diubiquitin with enhanced affinity. We 
solved solution NMR structures of the UBL domain and a helical domain that precedes the 
protease. Our structural studies suggest that the helical domain could serve as a landing platform 
for protease substrates in cooperation with attached ubiquitin chains binding to the UBL and UBA 
domains. 
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4.3. PUBLICATION III: 
The yeast proteases Ddi1 and Wss1 are both involved in the DNA 
replication stress response 
 
Svoboda M., Konvalinka J., Trempe J.F. and Grantz Šašková K. The yeast proteases Ddi1 and 
Wss1 are both involved in the DNA replication stress response. DNA Repair. 80, 45–51 (2019). 
My contribution: experimental design; cloning of all used DNA constructs; yeast 
phenotypic assays; yeast transformation; complementation assays; protein expression analysis; data 
analysis; wrote the manuscript. 
4.3.1. Motivation of the study 
Although DDI1 was initially identified in a high throughput screen looking for genes with 
the expression level responsive to treatment with chemicals causing DNA damage (DDI1 stands 
for DNA Damage-Inducible 1), little was known about the molecular mechanism, by which yeast 
DDI1 contributes to countering DNA damage. In addition to known options available for the cell 
to counter DNA damage, a novel pathway was recently identified involving direct proteolysis of 
protein-based lesions blocking the progression of the replication fork. In this pathway 
metalloprotease of Wss1p/SPRTN family is recruited to the blocked fork site and cleaves off the 
protein part of the lesion. Surprisingly, large screens for synthetic lethality of gene-pair deletions 
identified yeast DDI1 as a gene with strong synthetic lethality/sickness once deleted together with 
yeast WSS1. With this synthetic sick pair of proteases, a hypothesis of yeast Ddi1p involvement in 
the clearance of protein-based replication barriers arose. Therefore, we decided to find out whether 
yeast Ddi1p acts in countering the so-called replication stress, whether it is the protease domain of 
Ddi1p that facilitates this function, which of the other Ddi1p domains are involved, and whether 
this function could be functionally complemented by human homologues of DDI1. To answer the 
question, we employed methods of classical yeast genetics with phenotypic assays and functional 
complementation assays.  
4.3.2. Simultaneous deletion of DDI1 and WSS1 renders yeast cells 
hypersensitive to hydroxyurea 
To test whether Ddi1p participates in replication stress countering or other DNA damage 
response mechanisms, I performed a phenotypic assay to assess the effects of various agents 
causing DNA damage on the growth of Δddi1, Δwss1 double-deleted yeast strain. As can be seen 
in figure 13, the weak effect of methyl methanesulfonate and formaldehyde on Δddi1, Δwss1 strain 
was observed out of the panel of all tested compounds. On the other hand, ribonucleotide 
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reductase inhibitor hydroxyurea had a strong inhibitory effect over a broad range of concentrations 




Figure 13: The Δddi1, Δwss1 strain is hypersensitive to hydroxyurea. Dilution spot assays 
testing the viability of wild-type, single knock-out, and double knock-out strains under the 
influence of different DNA damage-causing chemicals. Equal amounts of exponentially 
growing cells were plated in serial dilutions on plates containing either YPDA media only 
or YPDA supplemented with formaldehyde (FA), methyl methanesulfonate (MMS), 
hydrogen peroxide (H2O2), hydroxyurea (HU), or camptothecin (CPT). 
 
4.3.3. Hydroxyurea hypersensitivity can be rescued by DDI1 overexpression 
in an active site-dependent manner 
To test whether the hydroxyurea hypersensitivity phenotype is caused by the absence of  
Ddi1p protein rather than disruption of gene regulatory elements, I performed a rescue experiment 
where the Δddi1, Δwss1 strain was transformed by plasmids driving the overexpression of either 
wild type or point mutated variants of yeast DDI1. Figure 14 shows that hydroxyurea 
hypersensitivity can be rescued by overexpression of the wild type yeast Ddi1p protein. The rescue 
was independent of the presence of known phosphorylation and ubiquitination sites as well as 
cysteine 300, described previously as residue required for proper nuclear localization. On the other 
hand, a single amino acid mutation of the catalytic active site aspartate 220 to either asparagine or 
alanine completely abolished the ability of yeast Ddi1p to counter the hydroxyurea hypersensitivity, 
suggesting a crucial role of the yeast Ddi1p proteolytic activity in the mechanism.  




Figure 14: Retroviral protease-like (RVP) domain catalytic activity is indispensable for 
complementation of hydroxyurea sensitivity. Equal amounts of exponentially growing cells 
transformed with single-copy plasmids overexpressing point-mutated variants of Ddi1p 
protein under the control of the Glyceraldehyde-3-phosphate dehydrogenase (GPD) 
promoter were plated in 7-fold serial dilutions on one YPDA plate supplemented with 
50 mM hydroxyurea. 
 
4.3.4. HDD domain is indispensable for the Ddi1p function in replication 
stress response 
Knowing that the hydroxyurea hypersensitivity of the Δddi1, Δwss1 strain can be rescued by 
yeast DDI1 overexpression in an active site-dependent manner, I analyzed the requirement for 
particular domains of yeast Ddi1p for the rescue phenotype. I prepared truncated constructs of 
yeast DDI1 lacking each known individual domain of the protein and performed a rescue 
experiment. Figure 15 shows that, as expected, the deletion of the RVP (aa 202-315) domain 
produces a phenotype identical to the mutation of catalytic aspartate 220. Surprisingly, the same 
phenotype was observed for the deletion of the HDD domain, more specifically its second helical 
bundle (aa 148-191). This observation can be partially explained by the vicinity of the HDD domain 
to the RVP domain and its hypothetical role as a proteolysis substrate landing platform.  




Figure 15: Retroviral protease-like (RVP) domain and a helical bundle (HDD) preceding 
the RVP domain are indispensable for complementation of hydroxyurea sensitivity. Equal 
amounts of exponentially growing cells transformed with single-copy plasmids 
overexpressing variants with deletions of known structured domains of Ddi1p under the 
control of the GPD promoter were plated in 7-fold serial dilutions on one YPDA plate 
supplemented with 50 mM hydroxyurea. All spots were done on the same plate.  
 
4.3.5. The DDI1 function in replication stress response is neither UBL nor 
UBA dependent 
To further explore the mechanism behind yeast Ddi1p action in countering hydroxyurea-
caused replication stress I identified the minimal part of yeast Ddi1p necessary and sufficient for 
the rescue of the hydroxyurea hypersensitivity phenotype. I prepared several truncated variants, 
with both N- and C-terminal truncation, and analyzed those constructs in the complementation 
assay. As can be seen in figure 16, both UBL and UBA domains are dispensable for yeast Ddi1p 
function in hydroxyurea tolerance, as the construct lacking both (aa 81-389) is capable to rescue 
the phenotype. The minimal construct, sufficient to fill the role of Ddi1p in the DNA replication 
stress response, spanned amino acids 146-322 and therefore covered the second helical bundle of 
HDD domain and the RVP domain. 




Figure 16: Complementation of hydroxyurea sensitivity by DDI1 overexpression does not 
require the ubiquitin-like and ubiquitin-associated domains of Ddi1p. The minimal 
construct capable of complementation spans residue 146 to residue 322, covering the 
second multi-helical bundle of HDD domain and the RVP domain. Dilution spot assays 
with 7-fold serial dilutions of cells overexpressing truncated variants of Ddi1p protein plated 
on YPDA supplemented with 50 mM hydroxyurea are shown. All 16 spot tests were done 
on one plate. 
 
Due to the loss of anti-Ddi1p antibody detection of some of the truncated variants, we 
performed an identical dilution spot experiment using C-terminally HA-tagged Ddi1p protein 
variants and obtained the same results.  
4.3.6. Human Ddi1-like proteins are capable of partial complementation of 
DDI1 function 
To assess whether the replication stress countering ability applies also for human 
homologues of Ddi1-like proteins, I performed complementation experiments with 
overexpression of both human DDI1 and DDI2. Surprisingly, both DDI1 and DDI2 are capable 
of partial functional complementation (figure 17) with the weaker effect compared to yeast DDI1. 
Nevertheless, rescue by human homologues is also dependent on the presence of the putative 
catalytic aspartate, and the difference between human and yeast homologues pronounces with 
decreasing temperature, pointing towards enzymatic reaction with different temperature optima as 
an underlying mechanism.  




Figure 17: Human DDI1 and DDI2 are capable of partial, proteolysis dependent, 
complementation of hydroxyurea sensitivity. Dilution spot assays with 7-fold serial dilutions 
of cells overexpressing A) yeast and human Ddi1-like proteins, cultured under two different 
temperatures, and B) their respective catalytically inactivated mutant variants. All spots were 
plated on YPDA plates supplemented with 50 mM hydroxyurea. 
 
4.3.7. Conclusion 
In this publication, we identified a hydroxyurea hypersensitivity in double-mutated Δddi1, 
Δwss1 yeast strain. Hydroxyurea acts as a ribonucleotide reductase inhibitor and causes stalling of 
the replication fork and subsequent replication stress. Yeast Ddi1p protein overexpression counters 
hydroxyurea hypersensitivity phenotype and rescues to normal growth in Δddi1, Δwss1 strain. 
Ddi1p function in this context is protease activity-dependent and requires the presence of the 
second helical bundle of the HDD domain. Surprisingly, neither UBL nor UBA domains are 
required for the rescue, therefore excluding the so-called proteasome shuttling mechanism and 
pointing towards mechanism based on direct proteolysis. Taken together, our data suggest the 
existence of a dual protease mechanism providing yeast cells with the ability to overcome 
DNA-replication stress caused by hydroxyurea, the ribonucleotide reductase inhibitor and known 
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5. DISCUSSION 
Ddi-1 like proteins forms a unique family of retroviral protease domain-containing proteins 
conserved through all sequenced eukaryotic organisms [Krylov and Koonin, 2001]. Despite the 
high level of conservation, only the yeast orthologue, DDI1, was studied more extensively. It was 
identified as a gene product with expression stimulated by treatment with DNA damaging 
chemicals, potential cell cycle regulator, and a participant in the ubiquitin-proteasome system [Liu 
and Xiao, 1997, Zhu and Xiao, 1998, Kaplun et al., 2005, Clarke et al., 2001]. In parallel, another 
group identified yeast DDI1 as a regulator of constitutive exocytosis, acting via phosphorylation 
regulated network of interactions with SNARE proteins [Lustgarten and Gerst, 1999]. Ddi1-like 
proteins from other eukaryotic organisms remained understudied, except for isolated reports on 
fruit fly rngo [Morawe et al., 2011], C. elegans ddi-1 [Guthmueller et al., 2011], and, recently, a set of 
papers describing the role of human DDI2 in the regulation of expression of proteasome subunits 
[Koizumi et al., 2016, Chowdhury et al., 2017]. Surprisingly, despite the identification of the first 
member of the Ddi1-like family, yeast DDI1 as a gene induced by DNA damage more than twenty 
years ago [Liu and Xiao, 1997], the molecular mechanism behind the inducibility, or the particular 
function of Ddi-1 like proteins in response to DNA damage remained elusive. We, therefore, 
decided to shed some light on Ddi1-like proteins function in this process.  
First, we focused on the understudied human DDI2 protein. Combining biophysical and 
biochemical methods, we reported the first structural and functional analysis of this protein. 
Ddi1-like protein family is an integral part of the UPS. Interestingly, human DDI2 did lose its UBA 
domain to the downstream RSC1A1 gene in a gene insertion event. We, therefore, explored other 
possible interaction interfaces enabling a functional connection to the UPS via interaction with 
ubiquitin. We identified a UIM motif on the very C-terminal alpha-helix of human DDI2, analyzed 
its interaction with ubiquitin, and found the interaction is weak, yet specific. During the preparation 
of this manuscript, Nowicka and colleagues published a paper describing a new paradigm in 
ubiquitin binding structural elements, showing that the UBL domain of yeast Ddi1p protein is 
binding to ubiquitin via complementary surface electrostatic charges [Nowicka et al., 2015]. We 
solved the NMR structure of the human DDI2 UBL and showed that the surface charge 
distribution for this domain differs significantly from its yeast homologue, with the overall charge 
on the potential interaction interface more neutral. Different electrostatic potential distribution, 
compared to the yeast homologue, explains significantly weaker, but still specific, interaction with 
ubiquitin, we observed in NMR titrations. In contrast, we did not observe any interaction with 
polyubiquitin chains, tested in the pull-down experiment with diubiquitin conjugates of all eight 
native linkages. Reports of others published later on show the human DDI2 role in the processing 
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of TCF11/NRF1, transcription activator responsible for driving proteasome subunit transcription 
upon UPS inhibition [Koizumi et al., 2016]. Here, in contrast with our results, human DDI2 activity 
appears to be ubiquitination dependent. The disagreement between our results and results from 
Murata lab could be explained by the minimum length requirement for the polyubiquitin chain. 
This in vivo observation can be explained by an orchestrated action of four weak-affinity 
ubiquitin-binding modules present in the DDI2 homodimer that might bring sufficient avidity to 
mediate a productive polyubiquitin interaction as observed by Koizumi et. al. In our experiments, 
we used only diubiquitin chain in vitro. Indeed, a recent publication by Dirac-Svjestrup and 
colleagues elucidated this situation, showing that cell lines with DDI2 gene knocked-out accumulate 
high molecular, highly polyubiquitinylated protein conjugates and that human DDI2 can directly 
process TCF11/NRF1, but requires very long polyubiquitin chain decoration, probably as a 
substrate recognition motif [Dirac-Svejstrup et al., 2020]. Human DDI2 does, therefore, bind 
polyubiquitin chain, but preferentially long ones. The exact molecular mechanism behind human 
DDI2 recognition and preference for long polyubiquitins remains to be clarified.  
Besides the UBL-UBA (or, in mammalian Ddi1-like proteins, the UBL-UIM) architecture, 
another characteristic feature of Ddi1-like proteins is the presence of retroviral aspartic protease 
domain in the central portion of their sequence [Krylov and Koonin, 2001]. We solved the 
three-dimensional structure of human DDI2 RVP using X-ray crystallography. Our structure 
revealed a canonical fold of retropepsin family of aspartic proteases very similar to the previously 
published structure of yeast Ddi1p RVP [Sirkis et al., 2006], structure of yeast Ddi1p RVP from 
our back to back publication, unpublished structural genomics consortia structure of human DDI1 
RVP (PDB code 3S8I) or, more generally, HIV-1 protease and other homodimeric aspartic 
proteases from retroviruses. On the structural level, human DDI2 RVP harbours all important 
determinants of aspartic protease activity. The bottom of the structure consists of the multiple 
beta-sheet-formed dimerization interface and the active site cavity is covered from the top by a pair 
of flexible beta-hairpins, so-called flaps. At the bottom of the active site cavity resides the catalytic 
Asp-Ser-Gly triad in a typical “fireman's grip” coordination [Strisovsky et al., 2000], binding a 
putative catalytic water molecule that serves as a nucleophile in the prospective proteolytic reaction. 
The only striking difference between human DDI2 RVP (and RVPs of Ddi1-like proteins in 
general) and aspartic proteases from retroviruses is a more spacious active site cavity, capable of 
accommodation of bulkier substrates and thus pointing toward possible cleavage of partially 
unfolded proteins instead of peptides. With all determinants of proteolytic activity present, it took 
us by surprise that we were unable to detect any in vitro proteolytic activity for neither isolated RVP 
nor the full-length human DDI2 protein under none of the various conditions we tested. We 
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employed an expressed proteome-based peptide library approach (PICS), as well as nonspecific 
cleavage of proteins and a large panel of known HIV-1 protease and other aspartic protease peptide 
substrates, all assayed under various pH and salt concentrations. None of these experiments led to 
a measurable proteolytic activity that we could ascribe to RVP.  Indeed, although there was plenty 
of data suggesting the functional importance of catalytic activity for cell physiology in different 
species [Diaz-Martinez et al., 2006, Gabriely et al., 2008, Morawe et al., 2011, White et al., 2011a], 
no one, except for a solitary publication on Ddi1-like protein from protozoa Leishmania major under 
nonphysiological, very acidic conditions [Perteguer et al., 2013], ever reported a biochemical assay 
for in vitro enzymatic activity of Ddi1-like protein. Even in an article focused on the human DDI2 
role in the processing of TCF11/NRF1, proteasome subunits transcription activator, with solid 
evidence for the requirement for RVP catalytic activity,  authors explicitly stated that despite 
multiple attempts they were not able to biochemically reconstitute the RVP proteolytic activity in 
vitro [Koizumi et al., 2016]. The above-mentioned recent publication by Dirac-Svejstrupup and 
colleagues shed light on this problem as well, proving that human DDI2 does have a proteolytic 
activity that can be assayed even in vitro, but the substrates must be polyubiquitinylated, with a 
strong preference for high molecular weight polyubiquitin conjugates. In agreement with our 
results, Dirac-Svejstrupup did not observe any deubiquitinylating activity of human DDI2 [Dirac-
Svejstrup et al., 2020]. The detailed molecular mechanism of RVP proteolysis, particularly the 
process of long polyubiquitin recognition and passing of the information on the proteolytic part 
of the protein with the following activation of proteolysis though remains elusive.  
The second part of this dissertation is focused on the Ddi1p protein of budding yeast 
Saccharomyces cerevisiae. We started with a detailed structural and biochemical characterization of the 
protein, solving three-dimensional structures of the UBL, HDD, and RVP domains and 
investigating interactions between the UBL domain and its suspected binding partners. 
Surprisingly, while analyzing the interaction between yeast Ddi1p and ubiquitin, we detected an 
unexpected stoichiometry of 2:1 for the interaction, although yeast Ddi1p harbours only one UBA 
domain. During our work on this manuscript, a publication by Nowicka and colleagues revealed a 
novel, unorthodox ubiquitin binding mode for yeast Ddi1p [Nowicka et al., 2015]. In their 
experiments, the UBL domain interacted with ubiquitin via a complementary charged surface, 
explaining the higher stoichiometry we observed. Based on the publication, we analyzed the 
UBL - ubiquitin interaction in an ITC experiment. However, our results differ from data from 
Nowicka et. al. Although we observed a ubiquitin interaction for both UBL and UBA, in our 
measurement UBA was the tighter binder of ubiquitin. This discrepancy could be explained by the 
different experimental setup, as we used a different method (ITC versus NMR), different buffer 
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(HEPES pH 7.4 versus sodium phosphate pH 6.8), and the UBL construct containing the initiator 
Met1, which alters the position of Asp2 involved in the interaction with ubiquitin. Moreover, 
compared to Nowicka‘s NMR titrations on isolated domains, our ITC experiments were carried 
out in the context of full-length, dimeric proteins. Despite minor discrepancies, our data are 
consistent with the yeast Ddi1p protein harbouring two independent ubiquitin interacting moieties.  
We reported a structure of yeast Ddi1p RVP as well. In general, our structure is similar to 
the earlier published structure of yeast Ddi1p RVP by Sirkis [Sirkis et al., 2006] and RVP structures 
from other Ddi1-like proteins. Our structure indicates interaction of the yeast Ddi1p RVP active 
site with the N-terminus of the adjacent molecule as observed in the crystal lattice. The interaction 
is mediated by extended beta conformation formed with a conserved loop of one of the flaps, 
adjacent to the active site. The extensive network of hydrogen bonds keeps the N-terminus in the 
active site, in the position expected to be occupied by a substrate of the RVP domain. Although 
the observed interaction probably originates from a crystallization artifact and there is little to none 
physiological importance for it, mechanistically, such observation points toward the molecular 
details of proteolysis by RVP and likely represents a model of substrate engagement. The pseudo-
substrate N-terminal segment here adopts a conformation similar to HIV-1 protease peptide 
substrates.  
Encouraged by a promising result from the structural study, we explored a putative yeast 
Ddi1p RVP proteolytic activity in biochemical in vitro assay. Here, we employed a PICS method 
used also in our back to back publication with human DDI2. We used full-length yeast Ddi1p 
protein, as well as isolated RVP domain, with exponentially growing yeast culture-derived peptide 
libraries under several assay conditions. Like its human orthologue, yeast Ddi1p did not exhibit any 
protease activity in our proteomic screen. While this could be interpreted as that this domain might 
simply not be a protease, it could also be that the protease is activated only in the context of its 
interactions during its physiological function. The newly identified HDD domain could serve as a 
substrate landing platform in this context. Our hypotheses on yeast Ddi1p activation were later 
confirmed by Yip and colleagues in a recent publication, where they described activation of yeast 
Ddi1p by substrates bearing long polyubiquitin chains [Yip et al., 2020]. The mechanism behind 
polyubiquitin-caused Ddi1-like protein activation in proteolysis thus appears conserved throughout 
species.   
In a follow-up publication, we focused on the identification of yeast DDI1 function in 
response to treatment with DNA damaging agents. Despite its identification as a gene product with 
expression induced by treatment with methyl methanesulfonate, a genotoxin [Liu and Xiao, 1997], 
the function of yeast DDI1 in DNA damage response remained unknown. We decided to take 
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advantage of the simple setup for gene modification in yeast and analysis of the phenotype of 
individual mutants or their combinations. We used a yeast Synthetic Genetic Array as a starting 
point. In this method, exploring a synthetic lethality between double mutated strains with an array 
of deleted gene pairs, DDI1 exhibited a strong negative genetic interaction with WSS1, replication 
stress countering protease [Costanzo et al., 2016]. By testing several typical DNA damage-inducing 
chemicals on Δddi1, Δwss1 yeast strain as well as on the wild type and single mutated strains, we 
found the double deleted strain to be highly sensitive to hydroxyurea. Hydroxyurea acts as an 
inhibitor of ribonucleotide reductase, an enzyme responsible for converting ribonucleotide 
triphosphates to deoxyribonucleotide triphosphates and thus providing building blocks for DNA 
replication [Elford, 1968]. Inhibition of ribonucleotide reductase by hydroxyurea results in 
replication stress, replication fork stalling, and, if not resolved, even to replication fork collapse 
[Petermann et al., 2010]. We observed a mild hydroxyurea sensitivity in WSS1 deleted single mutant 
strain as described previously [O’Neill et al., 2004]. The synthetic effect of both mutations 
substantially potentiated hydroxyurea sensitivity, beyond simple additivity. This suggests that 
Ddi1p and Wss1p act in two independent pathways, each counteracting the replication stress 
caused by hydroxyurea. Such observation is in agreement with results from Kottemann and 
colleagues, who identified human DDI1 and DDI2 as proteins involved in the degradation of the 
replication termination factor RTF2, facilitating restart of stalled replication forks after replication 
inhibition by, for example, hydroxyurea [Kottemann et al., 2018]. Interestingly, Wss1p was 
identified earlier as a protease clearing the protein part of DNA-protein crosslinks [Stingele et al., 
2014]. Hydroxyurea, though, is not known to cause DPC‘s and our observation thus raises a couple 
of questions. It remains to be clarified which DNA damage response pathway, triggered by 
hydroxyurea, leads to growth arrest when both DDI1 and WSS1 are lost. The double deletion strain 
may experience the upregulation of checkpoint pathways in the S phase, which induces cell cycle 
arrest upon DNA damage. Other important questions we did not address by our results, such as  
which substrate(s) are cleaved by the Ddi1p protease domain in this context and whether the target 
molecule is the same for Wss1p, remain to be answered.  
Next, we focused on a more detailed understanding of yeast Ddi1p function in the process. 
By overexpressing variants of the protein in the double knock-out background, followed by spot 
test phenotypic assay, we found out that although the hydroxyurea hypersensitivity phenotype is 
fully rescued by yeast Ddi1p reintroduction by overexpression, a single point mutation in putative 
catalytic aspartate renders the protein completely ineffective, leading to the phenotype of 
background double knockout strain. This represents yet another function of a protein from the 
Ddi1-like family, dependent on protease activity, and, together with other identified proteolysis 
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dependent functions, highlights the importance of the proteolytic activity of Ddi1-like proteins in 
cell physiology. The following experiment with complementation by truncated variants of the 
protein, lacking the whole individual folded domains corroborated our results. The protein variant 
missing the RVP presented the same phenotype as did the catalytic aspartate point mutant. 
Surprisingly, another construct we used, a protein lacking the HDD domain, or more specifically 
its second helical bundle, was also incapable of functional complementation. In a reverse 
experiment, aimed at the identification of a minimal yeast Ddi1p construct capable of functional 
complementation, we found that a protein construct spanning only the second helical bundle of 
the HDD domain and the RVP domain (aa 146-322) is sufficient to rescue the phenotype. This 
came as a surprise, as many publications focused on yeast Ddi1p pinpoint its role as the putative 
proteasomal shuttling protein [Voloshin et al., 2012, Diaz-Martinez et al., 2006]. The proteasomal 
shuttling mechanism was also proposed as a basis of the mammalian orthologues, human DDI1, 
and human DDI2 role in the degradation of RTF2 and subsequent restart of replication forks 
[Kottemann et al., 2018]. Our data suggest that in this case, we can exclude not only the 
proteasomal shuttle but as well the so-called alternative shuttle mechanism, proposed by Nowicka 
[Nowicka et al., 2015], as we observed full rescue even with constructs lacking any 
ubiquitin-binding moieties whatsoever. We, therefore, proposed a dual protease mechanism for 
hydroxyurea-caused DNA replication stress tolerance.  
Interestingly, almost all of our results were independently corroborated in a manuscript 
published a couple of months after our publication [Serbyn et al., 2020]. Serbyn and colleagues 
addressed a set of questions very similar to the one we asked. They show that yeast DDI1 is crucial 
for one of three partially redundant pathways for clearing proteins covalently trapped on DNA 
strand the other two being centered around WSS1 protease and 26S proteasome. In agreement 
with our data, they observed hypersensitivity of Δddi1, Δwss1 yeast strain (although in the different 
genetic background) to hydroxyurea, as well as the requirement of RVP catalytic activity and the 
presence of HDD domain for successful Ddi1p complementation. However, Serbyn et. al. went a 
step further showing Ddi1p localization in the nuclear fraction, its direct association with 
chromatin, and, most interestingly identified the core Pol II component Rpb1p (RNA 
polymerase II subunit B1) as a probable substrate involved in yeast Ddi1p proteolysis mediated 
replication stress response. Interesting information could be found also in the supplementary data 
accompanying Serbyn’s publication. Here they showed that although UBL is not required for 
rescue under overexpression of yeast Ddi1p, where the cell is flooded with the overexpressed 
protein, once expressed from a native promotor, UBL suddenly becomes essential for the rescue. 
More details, filling some blanks left in ours as well as Serbyn‘s papers come from a recent 
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publication by Yip and colleagues. Here they found that, like its human orthologue, yeast Ddi1p is 
an active protease that requires very long polyubiquitin chain decorated substrates. They 
established an in vitro biochemical assay and analyzed various truncated constructs of yeast Ddi1p. 
In agreement with our data, they showed that construct lacking HDD domain is incapable of 
proteolysis, construct spanning HDD and RVP domains possesses rather weak proteolytic activity 
as does a construct lacking the UBL domain. Full-length and UBA lacking constructs are on the 
other hand fully active [Yip et al., 2020]. This provides a possible explanation for the discrepancy 
between our data and results published by Serbyn. In DDI1 overexpressing cells, a high 
concentration of overexpressed protein substitutes for the low proteolytic activity of truncated 
variants. In cells expressing from the native promotor, propper activation/localization is 
paramount due to the normal physiological level of protein expression.  
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6. CONCLUSION 
The focus of this doctoral thesis was to investigate the function of the Ddi1-like family of 
proteins with an emphasis on their role in DNA damage related processes and response to the 
replication stress. To fulfill those goals, we employed a combination of biochemical and biophysical 
methods as well as tools of the classical yeast genetics.  
First, we biophysically and structurally characterized human DDI2 protein. We analyzed the 
structure of the UBL domain, assessed its surface charge distribution, and analyzed the interaction 
of the UBL domain with ubiquitin and ubiquitin chains. Furthermore, we performed proteolytic 
activity assays on the RVP domain of human DDI2 but were not able to detect any proteolytic 
activity we could attribute to the protein.  
In the second part, we focused on Saccharomyces cerevisiae orthologue, yeast Ddi1p protein. 
First, we performed a detailed analysis of its interaction with ubiquitin and K48-linked diubiquitin, 
revealing higher stoichiometry for the interaction and corroborating the earlier reported 
unorthodox ubiquitin binding mode, mediated by the UBL domain. Despite promising results from 
yeast Ddi1p RVP structural studies, we were unable to detect any proteolytic activity for this 
domain in the in vitro biochemical assay.  
In the third part, we focused on the characterization of Ddi1-like proteins function in the 
cellular response to DNA replication stress. We decided to utilize the yeast model since it provides 
facile methodology for the genetic screens of mutant combinations that would be much more 
labourious and time consuming in a mammalian model. We observed hypersensitivity to the DNA 
replication blocking drug hydroxyurea in the yeast strain with double deletion of DDI1 combined 
with a DNA dependent metalloprotease WSS1. Further analysis showed that the hydroxyurea 
hypersensitivity phenotype can be rescued by overexpression of yeast Ddi1p as well as its 
mammalian orthologues, human DDI1, and human DDI2. Ddi-1 like proteins function in this 
context is dependent on the functional RVP domain and presence of newly identified HDD 
domain, directly preceding the RVP domain in the protein sequence.  
Taken together, we structurally characterized both human and yeast orthologues from the 
Ddi1-like protein family analyzed their interaction with ubiquitin and discovered yeast Ddi1p 
function in a dual protease mechanism of preventing DNA replication stress. Unexpectedly, by the 
time we started to study this class of proteins, it appeared that at least in higher organisms, the 
abbreviation Ddi1 represents purely a denomination and that it does not reflect the biological role 
of the protein family. We spent several years looking for the evasive biological function of proteins 
from the „DNA damage“ family only to find out that they indeed do have a role in DNA damage. 
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8. SUPPLEMENTS  
 
8.1. SUPPLEMENT S1:  HUMAN DNA DAMAGE-INDUCIBLE 2 PROTEIN 
IS STRUCTURALLY AND FUNCTIONALLY DISTINCT FROM ITS 
YEAST ORTHOLOG 
 
Sivá M.*, Svoboda M.*, Veverka V., Trempe J.F., HofmannK., Kožíšek M., Hexnerová R., 
Sedlák F., Belza J., Brynda J., Šácha P., Hubálek M., Starková J., Flaisigová I., Konvalinka J., and 
Grantz Šašková K. Human DNA-damage-inducible 2 protein is structurally and functionally 
distinct from its yeast ortholog. Sci Rep. 6, 30443 (2016). 
 
* Equal contribution. 
 
My contribution: cloning of ΔUIM and catalytically inactive D252A variants of human 
DDI2; bacterial expression and purification of full length human DDI2 protein, it’s RVP domain 
and catalytically inactive variants of both; expression and purification of epitope-tagged full-length 
human DDI2 in mammalian cells; enzymatic synthesis of diubiquitin chains, pull-down assays for 
testing human DDI2 – ubiquitin interaction; PICS proteomics screen for substrates of DDI2 
protease activity; BSA cleavage assay; surface electrostatics analysis.  
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8.2. SUPPLEMENT S2: STRUCTURAL STUDIES OF THE YEAST DNA 
DAMAGE-INDUCIBLE PROTEIN DDI1 REVEAL DOMAIN 
ARCHITECTURE OF THIS EUKARYOTIC PROTEIN FAMILY 
 
Trempe J.F., Grantz Šašková K., Sivá M., Ratcliffe C.D.H., Veverka V.,  Hoegl A., Menade M., 
Feng X., Shenker S., Svoboda M., Kožíšek M., Konvalinka J., and Gehring K. Structural studies 
of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic 
protein family. Sci Rep. 6, 33671 (2016). 
 
My contribution: cloning of ΔUBA and catalytically inactive D220A variants of yeast 
Ddi1p; expression and purification of full-length yeast Ddi1p protein, it’s RVP domain and 
catalytically inactive variants of both; expression and purification of ΔUBA variant of yeast Ddi1p; 
sample preparation and assistance with ITC measurement; K48-linked diubiquitin synthesis; PICS 
proteomics screen for substrates of Ddi1p protease activity.  
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8.3. SUPPLEMENT S3: THE YEAST PROTEASES DDI1 AND WSS1 ARE 
BOTH INVOLVED IN THE DNA REPLICATION STRESS RESPONSE 
 
Svoboda M., Konvalinka J., Trempe J.F. and Grantz Šašková K. The yeast proteases Ddi1 and 
Wss1 are both involved in the DNA replication stress response. DNA Repair. 80, 45–51 (2019). 
 
My contribution: experimental design; cloning of all used DNA constructs; yeast 
phenotypic assays; yeast transformation; complementation assays; protein expression analysis; data 
analysis; wrote the manuscript. 
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